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                                                      ABSTRACT 
 
BACKGROUND AND OBJECTIVE 
 
Snake bite poisoning is a major dreadful event to the human beings.  The 
complications related to kidneys are observed in majority of patients with 
poisonous snake bite.This study is an attempt to study the  various clinical profile 
of snake bite patients and evaluation of acute kidney injury in them. 
 
METHODOLOGY 
 
Fifty patients with snake bite induced acute kidney injury were selected randomly 
and their clinical profiles were analysed and  AKI was evaluated using noninvasive 
methods. 
 
RESULTS 
 
Out of 50 patients in the study, coagulopathy was observed in 100% of patients, 
dehydration in 68 % , russel viper among the common species of 68 %, cellulitis in 
52%, with no major advantage of giving high dose ASV  and early institution of 
ASV.  
 
 CONCLUSION: 
 
  Coagulopathy is a major factor in causing aki followed by dehydration and  russel 
viper bite. There is no major advantage in giving high dose ASV  or early 
institution of ASV or cellulitis .  
 
 KEY WORDS: Snake bite ; coagulopathy ; dehydration ; cellulitis ; AKI ; ASV. 
 
 
 
INTRODUCTION  
 
 
Snake  bite  causing  acute  kidney  injury  is  a  devastating disease  which  can  be  
 
easily  preventable  if  we  know  the  factors  causing  it.  By  studying  the  factors  
 
causing it we can easily  manage this problem. Snake bite can be poisonous or  
 
non poisonous  .  poisonous  snake  bite    cause  various  manifestations  ranging  
 
from  localized cellulitis  to neuroparalysis  and acute  kidney injury  and  
 
disseminated intravascular coagulation and even death.   
 
 
   Snake bite  is also a  major concern  regarding the countries economical point  
 
of  view.  The  loss  of  manpower  and the  amount  the  country spend for  the  
 
treatment  of  a  snake  bite  patients  should  take  into account.  Snake  bite  also  
 
cause  significant  morbidity ranging   from  loss  of  body parts  secondary to  
 
compartment  syndrome  and acute  kidney injury  leading to end stage  renal  
 
disease .   
 
 
  Snake  bite  also  gives  the  family members  the  major  anxiety and  also the  
 
patients. Malpractice of first aids like tight bandage , laceration of wound side  
 
can  cause  even  worsen  the  snake  envenomations  and  its  spread.  Native  
 
treatment  in some  areas  can be  followed.  This  can  even worsen and causes  
 
untoward  side  effects.  Acute  kidney injury in  snake  bites  in  most  time  is  self  
 
limiting and reversible in course time. Adequate hydration is the cornerstone of  
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treatment.  Timely  administration  of  antisnake  venom  can  also prevent  the  
 
development of acute kidney injury and can  retard the  progression of disease.  
 
There  are  many factors  in  snake  bite  can  also favour  the  occurrence  of  acute  
 
kidney injury. These studies focuses the factors which are more prone for acute  
 
kidney injury.   
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REVIEW OF LITERATURE  
 
 
CLINICAL  ANATOMY OF KIDNEY  
 
 
 
Kidneys  are  paired  retroperitoneal  organs  .  they  are  situated  in the  posterior   
 
side  of  the  abdomen.  They are  placed    on each  side  of  the  vertebral  column.   
 
upper  pole    lies  opposite  the  12th  thoracic  vertebra.  The    lower  pole    opposite  
 
the 3rd  lumbar vertebra. The right kidney  is  usually  lower  and left kidney  is  
 
higher in  position.  
 
 
 
The weight of  kidney  approximately  120 g to 160 g in male. In female 110 g 
 
to 150 g .  10 cm to 12 cm in length, width is  5.0 cm to 7 cm in, and 2.0 cm to  
 
3.0cm  in  thickness.  sinus  of  the  kidney    consists  of    renal  pelvis,  the  renal  
 
artery and vein, the  lymphatics, and a  nerve  plexus .  The organ  is surrounded  
 
by  a    capsule.  The  capsule  is    smooth  and  easily  removed.  kidney  is  supplied   
 
by  a  single  renal  artery.    In    the  hilar  region    renal  artery    divides  into     two  
 
branch.    segmental    arteries  arise  from  the  anterior  branch  and supply  the  
 
upper, middle, and lower thirds of the anterior surface of the kidney .  
 
 
 
The  posterior  branch  supplies    posterior  surface.      The  apical  segmental    is  a  
 
branch  from the anterior division.  There is no collateral circulation  .   
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The    aberrant  arteries  of  the  kidney  arise  from  the    from  the  superior  
 
mesenteric,  testicular,  or  ovarian  arteries.  True  accessory  arteries  supply the  
 
upper pole of the kidney.  
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THE NEPHRON  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The nephron is the functional unit of the kidney  . Each  kidney contains about   
 
millions of  nephrons. Each  nephron has  malpighian corpuscle , the proximal  
 
tubule, the thin limbs, the distal tubule, and the collecting  tubule. The nephron 
 
orginate  from  the    metanephric  blastema.    The  connecting tubule  derive  from  
 
the  metanephric  blastema.  The  ureteric  bud    gives  rise  to   collecting duct  
 
system  says  collecting  tubule,  the  cortical  coll  ecting  duct  (CCD),    outer  
 
medullary  collecting  duct  ,  and the  inner  medullary  collecting system.  
 
Functionally the  nephron  and the  collecting duct  system  are  acts  in the  same  
 
manner.  
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ACUTE KIDNEY INJURY :  
 
 
 
                          DEFINATION: Acute kidney injury (AKI) is  characterized by 
 
a  rapid   fall    in  the  glomerular  filtration  rate  .    It  also causes    retention  of  
 
nitrogenous waste products such as blood urea nitrogen (BUN) and creatinine1.  
 
The  term acute renal failure constitutes of three phases . it includes initiation,  
 
maintenance, and recovery phases. each  phases consists of    variable duration 
 
and severity.    On  comparing  to the  chronic  kidney  disease  the  acute  kidney 
 
injury is  more  dangerous  one  because  even mild  decrease  in glomerular  
 
filtration  rate may  associated with  unfavorable clinical outcomes. 
 
 
 
AKI  is classified asnonoliguric (urine output >500 mL/day), oliguric (urinary  
 
out-put <500 mL/day), or anuric (urinary output <150 mL/day) 2.Lower levels  
 
of urinaryoutput  have consequence of   severe initial injury, have implications  
 
for volume overload and electrolyte disturbances, and are of bad  prognostic  
 
importance. However, the therapeutic depending  onthe urine output does not  
 
change  this prognostic association .   
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In view of  diagnosis and management, AKI has been divided into three  
 
categories   
 
 
 
1.     Prerenal :  
 
          Decresed blood supply to the one or both kidneys. Causes commonly 
 
hypotension of variable cause.  
 
 
2.     Intrarenal :  
 
 Renal parenchymal tissue  is involved.  
 
 
3. 
Diseases involving large renal vessels,  
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• 
 
 
 
 
PRE RENAL AZOTEMIA :  
 
 
 
Prerenal  AKI  is  the  most  common  cause  of  AKI  and is  an      common 
 
physiologic  response  to renal  hypoperfusion 3  and hypotension 
 
consequence,  the  special  feature  of  this  is  ,  the  integrity  of  renal  
 
parenchymal tissue is intact and GFR is corrected rapidly with restoration 
 
of renal perfusion.The clinical and biochemical features of prerenal ARF  
 
and ischemic  ATN  coexist  in  many patients.Severe  renal  hypoperfusion 
 
may cause ischemic ATN. Thus, prerenal AKI and ischemic ATN are part  
 
of a common   manifestations of renal hypoperfusion,.  
 
 
 
Prerenal  AKI  can  complicate  any  disease  characterized by  hypovolemia,  
 
low cardiac output, systemic vasodilatation, or intrarenal vasoconstriction 
 
True or “effective”  hypovolemia  leads to a fall  in  mean systemic arterial  
 
pressure, which,  in turn, activates arterial   and cardiac baroreceptors and  
 
initiates  a  series  of  neural  and humoral  responses  that  include  activation 
 
of  the  sympathetic  nervous  system  and  renin-angiotensin-aldosterone  
 
system and release of antidiuretic hormone 4 . Noradrephrine, angiotensin 
 
II, and antidiuretic hormone act in concert in an attempt to maintain blood  
 
pressure  and preserve  cardiac  and cerebral  perfusion  by  stimulating 
 
vasoconstriction in  relatively “less  important”  vascular  beds  such as  the  
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musculocutaneousand splanchnic  circulations,  by  inhibiting  salt  loss  
 
through  sweat  glands,  by  stimulating  thirst  and salt  appetite,  and by 
 
promoting renal    water  and salt    retention.).  Intrarenal  biosynthesis  of  
 
vasodilator prostaglandins (e.g., prostacyclin, ), kallikrein and kinins, and  
 
possibly  nitric  oxide  (NO)  is  enhanced.  Angiotensin  II  may  induce  
 
preferential  constriction  of  efferent  arterioles,  probably  because  most  
 
angiotensin II receptors are  found at this  location  Glomerular perfusion,  
 
ultrafiltration  pressure,  and filtration  rate  are  preserved during mild  
 
hypoperfusion  through several  compensatory  mechanisms.  Stretch 
 
receptors in the walls of efferent  arterioles detect a reduction in perfusion  
 
pressure,  causing    dilatation    of  afferent  arteriolar  smooth  muscle  cells  
 
and vasodilatation (autoregulation).  As  a  result,  intraglomerular  pressure  
 
is  m,  the  fraction is    mintainedon of  renal  plasma  that  is  filtered by 
 
glomeruli (filtration fraction) is increased, and GFR is maintained.   
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TABLE 29-2  -- Major Causes of Prerenal Azotemia 
 
 
Gastrointestinal losses: vomiting, , diarrhea, nasogastric suction  
 
 
Hemorrhage:  
 
 
traumatic,  surgical,  postpartum  
 
 
blood  
 
loss,gastrointestinal,  
 
 
 
 
 
Renal  losses:  drug-induced  or  osmotic  diuresis,  diabetes  
 
insipidus, adrenal insufficiency.  
 
“Third-space”  
 
losses:  pancreatitis,  crush  
 
syndrome,  
 
hypoalbuminemia  
 
 
 
 
 
Skin  and mucous  membrane  losses:  burns,  hyperthermia,  and  
 
other causes of increased insensible losses  
 
 
 
 
 
 
Comparomised cardiac output:  
 
Pulmonary  hypertension, pulmonary embolism, positive-pressure  
 
mechanical ventilation    
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Diseases  of  myocardium,  valves,  pericardium,  or  conducting 
 
system  
 
 
 
 
 
Systemic vasodilatation  
 
 
Drugs:  ACE  inhibitors  ,  afterload reduction drugs  ,  anesthetics,  
 
drug overdoses  
 
 
Sepsis, liver failure, anaphylaxis  
 
 
 
Renal vasoconstriction 
 
 
Noradrenaline,  ergotamine,  liver  disorders  ,,  hypercalcemia,  
 
sepsis  
 
 
 
Agents  that  acutely impair  autoregulation  and  glomerular  
 
filtration rate in specific settings 
 
 
Severe  renal  hypoperfusion,  Angiotensin-converting enzyme  
 
inhibitors in renal artery stenosis   
 
 
Inhibition of  prostaglandin synthesis  by   NSAIDS  during renal  
 
hypoperfusion 
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These  compensatory  renal  responses  are  overwhelmed during  states  of  
 
moderate  to severe  hypoperfusion,  and ARF  ensues.).  Intrarenal  
 
biosynthesis  of  vasodilator  prostaglandins  (e.g.,  prostacyclin,  
 
prostaglandin E2), kallikrein and kinins, and possibly nitric oxide (NO) is  
 
enhanced. Angiotensin II  may induce preferential constriction of efferent  
 
arterioles,  probably  because  most  angiotensin  II  receptors  are  found at  
 
this  location  of  proximal  tubules  .Autoregulatory  dilatation  of  afferent  
 
arterioles  is  maximal at a  mean systemic arterial blood pressure of about  
 
60 to  90 mm  Hg,  and hypotension below  this  level  is  associated  with a  
 
precipitous decline in glomerular ultrafiltration pressure and GFR.  Lesser  
 
degrees  of  hypotension  may  provoke  prerenal  AKI  in  the  elderly,  in 
 
patients with renovascular disease, and in patients with diseases affecting 
 
the  integrity  of  afferent  arterioles  (e.g.,  hypertensive  nephrosclerosis,  
 
diabetic  nephropathy).In  addition,  very  high  levels  of  angiotensin  II,  as  
 
are found in patients with marked circulatory failure, provoke constriction 
 
of  both  afferent  and efferent  arterioles,  thus  negating the  relatively 
 
selective  effect  of  low  levels  of  this  peptide  on  efferent  arteriolar  
 
resistance.  
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Nonsteroidal  
 
 
 
 
 
 
 
 
anti-inflammatory  drugs  (NSAIDs),  
 
 
 
 
 
 
 
 
including 
 
cyclooxygenase  II  inhibitors,  decrease    renal  prostaglandin biosynthesis  
 
.Several  classes  of  commonly used    agents    impair  renal  adaptive  
 
responses  and can  change    compensated  renal  hypoperfusionto overt  
 
prerenal  AKI  or    cause    progression  of  prerenal  AKI  to ischemic  ATN.   
 
Similarly,  inhibitors  of  angiotensin-converting enzyme  (ACE)  and  
 
angiotensin II receptor blockers  may trigger prerenal AKI in individuals  
 
in whom intraglomerular pressure and GFR are depends on angiotensin II  
 
.They  do not  compromise  GFR  in  normal  individuals  but  it  may    cause  
 
prerenal    acute  kidney  injury  in  subjects  with  true  hypovolemia  or  
 
decreased effective  arterial  blood volume,  or  in  patients  with  chronic  
 
renal insufficiency in whom GFR is  maintained in part by prostaglandin- 
 
mediated hyperfiltration  through  remnant  nephrons..  ACE  inhibitors  and  
 
ARBs  attenuate these compensatory  responses and can  precipitate   AKI  
 
in such  patients.  ACE  inhibitors  or  ARBs,  like  NSAIDs,  may also  
 
precipitate  prerenal  AKI 5  in patients  with  compensated renal  
 
hypoperfusion  of  other  causes,  needed   close  monitoring  of  the  serum  
 
creatinine  level  when these  drugs  are  administered to  high-risk  
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individuals.  
 
 
 
 This complication is classically seen in patients with bilateral renal artery 
 
stenosis  or  unilateral  stenosis  in a  normally   functioning one    kidney.  
 
Here, angiotensin II preserves glomerular filtration pressure distal to renal  
 
arterial stenosis by increasing systemic arterial pressure and by triggering 
 
selective constriction of efferent arterioles norepinephrine, angiotensin II,  
 
antidiuretic  hormone.  The  classic  urinary and biochemical  sequelae  of  
 
prerenal  AKI  can  be  predicted from  the  stimulatory  actions  of,  and low  
 
urine  flow  rate  on  salt  and water  reabsorption  from  urine  and include  
 
concentrated urine  (specific  gravity >1.016,  osmolality >300mOsm/kg 
 
H2O,  low  urinary  Na+concentration,  and benign urine  sediment.prerenal  
 
ARF may be seen in patients with renal concentrating defects  in case of  
 
diabetes  insipidus  and in the  setting of  large  endogenous  or  exogenous  
 
solute loads. Hypernatremia due to increased free water losses is a clue to  
 
the presence of a increase urinary output prerenal state.  
 
 
 
Some  vasoactive    drugs,  and diagnostic  agents  like  iodide    stimulate  
 
intense intrarenal vasoconstriction and it cause glomerular hypoperfusion 
 
and acute  kidney injury    with  many  of  the  functional,  clinical,  and  
 
biochemical  features  of  prerenal  AKI.  Examples  include  hypercalcemia,  
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sepsis  
 
 
 
 
,radiocontrast  
 
 
 
 
agents,  
 
 
 
 
calcineurin 
 
 
 
 
inhibitors  
 
(cyclosporin,tacrolimus),  amphotericin  B,  cocaine,  and noradrenaline  
 
(e.g.,  therapeutic  administration,  pheochromocytoma,  brain  damage).  
 
Tacrolimusand cyclosporine  inhibitors  precipitate  ARF  by  inducing 
 
intrarenal  vasoconstriction  and hypoperfusion,  and by  stimulating 
 
mesangial cell contraction and a fall in glomerular filtration surface area.    
 
Tubular  necrosis  is  rare  in this  setting,  although  long-term  calcineurin 
 
inhibitiondrugs   may  lead to irreversible renal  impairment, probably as a  
 
results    of  obstructive  arteriopathy and  chronic  medullary  ischemia  
 
producing necrosis .  
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Acute Tubule Necrosis :  
 
 
The    term  ATN  and the  clinical  term  ARF/AKI  are    commonly used  
 
interchangeably  when  referring to ischemic  and nephrotoxic  renal  injury 
 
but  presence  of  frank necrosis of  renal tubules  and it  may also  sparse   
 
in most cases  and vise versa. 6 , The duration of cardiopulmonary bypass  
 
and  the  degree  of  preoperative  and  postoperative  complications  leads  to  
 
hypoperfusion  and hypotension  .  this  will  aggrevate  the  acute  kidney 
 
injury    especially  in  older  individuals  like  diabetic  mellitus.      It  should  
 
also be  noted that  the    that  extracellular  fluid losses  in  many  clinical  
 
situations    or  transient  renal  hypoperfusion  commonly   in  the  settings  of  
 
cardiac  arrest  or  aortic  cross  clamping    generally  do not  cause  acute  
 
tubular  necrosis    in  the  absence  of  existing renal  impairment  or  the  
 
presence    of  another  nephrogenic  insult  says  drug induced  ,  sepsis,  or  
 
rhabdoemyolysis,  leukemaoid reactions,  and other  consequences  . ] 
 
Prerenal  AKI  results  from  hypoperfusion.  It  will  reverts  once  the  
 
reperfusion is  maintained.  But  in  case  of  intrinsic  AKI      it  is  associated  
 
with injury to renal  tissue .It does not cured  immediately on restoration 
 
of renal perfusion.   
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The    term  ATN  and the  clinical  term  ARF/AKI  are    commonly used  
 
interchangeably  when  referring to ischemic  and nephrotoxic  renal  injury 
 
but  presence  of  frank necrosis of  renal tubules  and it  may also  sparse   
 
in  most cases  and vise  versa.  Prerenal  AKI and ischemic  ATN are part  
 
of  a    two spectrum  of  manifestations  of  renal  hypoperfusion  or  systemic  
 
hypotension  .  prerenal  AKI  being  a  response  to  mild  or  moderate  
 
hypoperfusion and ischemic  ATN being the result of  more, The duration 
 
of  cardiopulmonary  bypass  and the  degree  of  preoperative  and  
 
postoperative cardiac severe or prolonged hypoperfusion often coexistent  
 
with  other  renal  diseases  especially  in older  individuals  like  diabetic  
 
mellitus  is  highly influencing  .    It  should also be  noted that  the    that  
 
extracellular  fluid losses  in  many  clinical  situations    or  transient  renal  
 
hypoperfusion commonly   in the settings of cardiac arrest or aortic cross  
 
clamping  generally do not cause acute tubular necrosis  in the absence of  
 
existing renal  impairment  or  the  presence    of  another  nephrogenic  insult  
 
says  drug  induced ,  sepsis,  or  rhabdoemyolysis,  leukemaoid reactions,  
 
and other consequences   
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Ischemic  acute  tubular  necrosis  occurs  in  the  setting os  prolonged  
 
addominal  surgery,sepsis,  dehydration and  toxin mediated 7.    Acute  
 
tubular  necrosis    most  commonlyoccurs  in  aortic  surgery  in  case  of   
 
undergoing emergency  repair  of  ruptured abdominal  aneurysms    and  
 
other  major  intraabdominal  surgery  or  after  complicated elective  
 
procedures  requiring  prolonged (>45   minutes)  clamping  of  the  aorta  
 
above  the  origin of  the  renal  arteries  one  one  side  .  However,  50%  of  
 
cases  of  postsurgical  ATN  occur  in the  absence  of  documented  
 
hypotension.  ATN  occurs  in  50%  to 80%  of  patients  who suffer  burns  
 
involving more  than  25%  of  their  surface  area  and  it  is  a  frequently 
 
multifactorial  and due  to the  combined effects  of  hypovolemia,    most  
 
commonly  dehydration  ,  rhabdomyolysis,  sepsis,  and nephrotoxic  
 
antibiotics.  combination  of  systemic  vasodilatation  and intrarenal  
 
vasoconstriction    is  the  mechanism  behind the  sepsis  induces  renal  
 
hypoperfusion  provoking. 8 
 
 
 
       Exotoxins  and endotoxins  results  from  variable  causes  can  cause  
 
acute  kidney injury. Nephrotoxic  ATN   occurs  in   pharmacologic agents  
 
and poisons.  Some  metabolic  products  also can      cause  acute  kidney 
 
injury.It occurs in the settings   when it present at high concentrations in 
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the  circulation.  This  toxic  products  cause    intrarenal  vasoconstriction,  
 
direct  tubule  toxicity,  and intratubular  obstruction .  In general,  
 
nephrotoxins  cause  renal  The  kidney  is  particularly vulnerable  to  
 
nephrotoxic  injuryby virtue  of  its  rich blood supply.  the    countercurrent  
 
mechanisms of the medullary interstitium is responsible for this.   
 
 
 
 
 
 
Postrenal Acute Kidney Injury 
 
 
 
Urinary tract obstruction is one of the common cause for the acute kidney 
 
injury  the  obstruction  can  occurs  anywhere  between  the  urerter,  renal  
 
pelvis,  bladder,  urethra,  prostate  disease,  penile  structures.  prostatic  
 
disease  ,.  Neural  tube  defects  can  cause  neurogenic  bladder.  Anti  
 
cholinergic  drugs  can  also  cause  urinary tract  obstruction.    least  
 
commonly the Blood clotsin the urinary tract , calculi, and urethritis with 
 
spasm    are    less  common  causes  of  acute  lower  urinary  tract  obstruction 
 
.Ureteric  obstruction  may  result  from  intra  visceres    obstruction    like  
 
inadvertent  surgical  ligature.  .  This  results  in  gradual  distention  of  
 
proximal  ureter,  renal  pelvis,  and   other  structures  of  neoprhons  ,  and a  
 
fall  in  GFR.  initial  modest  increase  in  renal  blood flow,  arterial  
 
vasoconstriction  soon supervenes  as  a  consequence  of  acute  obstruction 
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leads to  acute kidney injury.  
 
 
 
PATHOGENESIS OF ACUTE KIDNEY INJURY :  
 
 
 
       The  effect  of  renal  injury,  whether  from  ischemia  or  from  other  
 
causes, is a  decrease in the GFR. This decrease GFR  often occurs in the  
 
absence    preexixting   evident  damage  to  the  kidney as  seen  on light  
 
microscopy.  There  are    three  major  mechanisms  are  commonly  
 
responsible  for the fall in GFR pertaining to acute kidney injury .The first  
 
mechanism    pertaining to the    drop  in  the  filtration  pressure  in the  
 
glomerulus. This drop in pressure is reflected in the nephron in the formof  
 
caused by  afferent  arteriolar  vasoconstriction  and proximal  tubular  
 
obstruction.  This  mechanism leads to a indirect fall in the GFR. Afferent  
 
arteriolar  vasodilation    is thought  to be a result  of endothelial cell  injury 
 
caused by  toxins  and other  insults    This  leads  to  an  imbalance  in 
 
vasoactive  substances  and counter  current  mechanism  in the  medullary 
 
interstitium  with a predominance of vasoconstrictive activity. The second  
 
mechanism is  tubular back-leakage syndrome characterized by the , leads  
 
to a fall in the  GFR because of the leak in the  tubules.. Damage and loss  
 
of  epithelial  cells    denuded basement  membranes  and loss  of  tight  
 
junctions between those cells that are critical to maintaining separation of  
 
 
 
20  
 
 
 
 
tubular  filtrate  and the  surrounding  interstitium  .  of  damage  and loss  of  
 
epithelial cells  denuded basement membranes and loss of tight junctions  
 
between those  cells  that  are  critical  to maintaining separation  of  tubular  
 
filtrate  and the  surrounding interstitium  .        This  syndrome  of  Back- 
 
leakage  of  glomerular  filtrate  occurs  in  the  setting Tight  junctions  are  
 
disrupted in  the  setting  of  adenosine  triphosphate    depletion,  allowing 
 
back-leakage of potassium  and other solutes into the renal interstitium.  .  
 
THP tends tojoined  and form a gel that can further trap cells and tubular  
 
cell debris following acute kidney injury  ATN further promotes THP gel  
 
formation .9 The concentration of various molecules in the renal tubules in 
 
evolving.  Besides  a  fall  in  GFR,  there  is  also a  decreased ability  of  the  
 
kidney to concentrate urine following AKI.   
 
 
 
Mediators of  Inflammation :  
 
 
 
Inflammation plays a central role in AKI. Repair, inflammatory cells and  
 
soluble  mediators  are  likely  major  determinants  of  the  outcome  from  
 
ARF. 10From  initiation  to extension  through  A  number  of  different  
 
inflammatory  cells  and soluble  chemokines  have  been  found to be   
 
thought  for  full  renal  damage  and loss  of  glomerular  filtration to  occur.  
 
Inflammatory  pathways  are  attractive  targets  for  therapy,  and there  has  
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been  great  success  with  interventions  in  experimental  models  of  AKI.  
 
blocking  inflammation  after  the  renal  insult  has  occurred affords  much 
 
less protection to the kidney is the limitation of this approach seems to be  
 
that   
 
 
 
Inflammation in microvessels :  
 
 
 
The microvasculature injury is the foremost  events leading to damage of  
 
renal tubular epithelial cells. The kidney receives 25% to 35% of cardiac  
 
output,  and most  of  that  blood  flow  is  directed to  the  renal  cortical  
 
structures.11    The  vasa  recta  branching  from  efferent  arterioles,  ,  
 
eventually become  the  vessels  of  Postglomerular  vessels.  countercurrent  
 
multiplier, allowing for more  trafficking of water and solutes is the low- 
 
flow state in the vasa recta is a critical aspect of the.  However, the low- 
 
flow  state  leaves  the  medulla  more  commonly   hypoxic  when compared  
 
with  other  regions  of  the  renal  structures  .  Very  slight  decreases  in  the  
 
blood flow and oxygen delivery can lead to hypoxic  damage. The reason 
 
behind the renal cortex with a partial pressure of oxygen of about 60  mm  
 
Hg, the medulla has a partial pressure of oxygen in the 20  to 30 mm Hg 
 
range  .  so consequently,  Anoxic  injury to local  cells,  including  vascular  
 
smooth  muscle  cells  resultant  disruption  of  their    cytoskeleton.This   
 
 
 
22  
 
 
 
 
cellular  deformities  erythrocyte  interactions  and  promotes  sludging of  
 
erythrocytes    in  a  and hypoxia  in  and around the  microvasculature  leads  
 
to endothelial-  way  that  is  analogous  to  a  sickle  cell  vaso-occlusive  
 
crisis.12.  Vascular  congestion  with  RBC  sludging has  been  described on 
 
renal biopsies. These studies have demonstrated that structures around the  
 
vase  recta    capillaries  had stopping of  of  blood flow  following  an 
 
ischemic  event  as  compared with  intraglomerular  capillaries  that  had  
 
diminished but  never absent  flow. Red blood cells Peritubular capillaries  
 
also took longer  to recover  normal  blood flowin  comparison with other  
 
intrarenal  vessels.  The  combination  ofanoxic  injury,  changes  in 
 
endothelial  cell  morphology,  contributes  to our  understanding of  the  
 
regionalization of injury within the kidney   
 
 
 
and  heightened interactions  between  and endothelium  leads  to  the  
 
extension of the initial renal injury .  
 
 
 
 
 
Leukocytes as mediator :  
 
 
 
  On biobsies of kidney   neutrophils Infiltration  are  infrequently seen of  
 
human  ATN  but  it  was  known  that  infiltrate  the  kidney  following  an 
 
ischemic  insult  in  experimental  animals  .  Decreased renal  injury occurs  
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when neutrophil migration and activity are blocked in  some experimental  
 
studies have demonstrated13.  Early inflammation is classically supported   
 
bymargination of neutrophils to endothelium.  
 
 
 
  Integrin pathway modulation can alter outcome of renal failure  through 
 
neutrophil-independent ways  . selectin ligands to reduce ischemic kidney 
 
injury in deceased donor  transplants    is  confirmed   multicenter  clinical  
 
trial is under way blocking.  
 
 
 
Blockade of the integrin CD11/CD18 protects from ARF .  
 
 
 
There  are  many other  key    chemokines    pathways  that  mediate  the  
 
pathogenesis  of  AKI.  Toll  receptors  also  found  to   have  likely play an 
 
important role. TLR1  has been shown to mediate experimental ischemic  
 
ARF,  and TLR43mediates  ARF  in  a  mouse    lipopolycechride  model.  .  
 
Many  of the cytokines play a  role  in ARF, which is a rapidly advancing 
 
and   interesting   area  of  investigation TLR8 and MyD88  have  been 
 
implicated in a mouse sepsis model.  
 
 
 
Apoptosis  
 
 
 
Apoptosis    pathophysiologically related  to    acute  renal  failure  .  cellular  
 
necrosis    and apoptosis  are  different  .  swelling of  cells,  loss  of  plasma  
 
 
24  
 
 
 
 
membrane  integrity,  by  and eventually  cell  rupture  with  spillage  of  
 
cellular  constituents    cellular  necrosis.  is  characterized contents  into the  
 
extracellular  space14.    In  apoptosis,  the  cell  nucleus  and cytoplasm  
 
condensation  and then split   into smaller   small  bodies.  Also  note that  
 
cytoplasmic organelles, including the mitochondria, are  are phagocytized  
 
by macrophages or other cells,  to cause inflammation.  
 
 
 
The  effects  of  apoptosis  on  the  host  can    change  during the  course  of  
 
AKI,  ranging from    deleterious  to whereas  during  the    convalescent   
 
phase, apoptosis may be an important mechanism to regulate cell number  
 
and  structure .  beneficial, depending on the phase of acute kidney injury 
 
.  Initially,  apoptosis  may  be  deleterious  to the  kidney  and overall  renal  
 
function,  The  signs  of  apoptosis  in the  kidney,  within 10minutes  of  a  
 
anoxic    insult  in  the  rat  kidney.  15  These  early  findings  of  apoptosis  
 
removal of necrotic tubular cells from the area, and may be a way to often 
 
precede  any  can  cause  deterioration in  renal  initially heralded by  DNA  
 
fragmentation in  the  cells  of  the  thick ascending limb,  can  be  seen  as  a  
 
function.  A second peak in the amount of apoptosis in renal tissue occurs  
 
days to weeks after the initial insult.  This  often follows help regulate the  
 
number of newly generated cells.  
 
 
 
 
25  
 
 
 
 
. Studies of cell culture found that the duration and severity of that injury 
 
often  correlates  with  the  type  of  donor,  deceased or  living,  and the  cold  
 
ischemic  time.  the  initial  hypoxic  injury  triggers  apoptotic  pathways  in 
 
some  cells,  but  Ischemic  renal  injury  can  occur  in  donar  kidney  in renal  
 
transplantation  patient.  if  there  were  differences  in  rates  of  apoptosis  
 
diseased   donor  kidneys  were  compared with  living donor  kidneys  to  
 
determine.  Very little apoptosis was found in the kidneys of live donors.  
 
Apoptosis  was  seen  in all  deceased donor    patients  ,  with a  differences   
 
between the duration of cold ischemic time and the amount of cell death .  
 
 
 
Animals treated with the caspase inhibitor before renal IRI had significant  
 
protection  from  renal  damage  and loss  of  renal  function,  but  that  
 
protection was  lost  if  animals  were  treated following the  onset  of  
 
apoptosis. The expression of caspases in the cascade of events leading to  
 
apoptosis was found to be a critical step in the release of proinflammatory 
 
mediators, such as endothelial monocyte-activating polypeptide-II, which 
 
can further induce P- and E-selectins.  
 
 
 
Blocking caspase  activity and apoptosis  has  been  the  target  of  other  
 
interventions,  often  successfully limiting renal  damage  in models  of  
 
ischemic  injury.  Minocycline,  the  tetracycline  antibiotic,  was  shown  to  
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block renal damage through reduction of apoptosis in a rat model of IRI.  
 
Other  studies  have  targeted different  pathways  of  apoptosis  EPO  
 
administration  can  protect  the  kidney  from  the  effects  of  IRI  in 
 
experimental  models 16.  Many  investigators  have  shown that  EPO  can 
 
decrease  the  number  of  apoptotic  tubular  epithelial  cells  from  an 
 
otherwise  lethal  dose  of  cisplatin.  effectively blocked caspase  cells  
 
following an  ischemic  insult.  Apoptosis  has  been  shown  to be  an 
 
important  pathway  of  injury  in  the  kidney in  other  models  as  well.  The  
 
use  of  cell  cycle  inhibitors  that  also -3 were  found to protect  cultured  
 
renal  Cisplatin  is  a  highly nephrotoxic  chemotherapeutic  agent  that  
 
damages cells .  
 
 
 
The Endothelial Cell  
 
      When  an initial  insult  damages  the  endothelium  of  the  renal  vessels,  
 
the result is an endothelial bed that is ineffective in regulating local blood  
 
flow and cell migration into tissues, and preventing coagulation. Damage  
 
to endothelial cells can also favourAKI ..This vascular dysfunction   leads  
 
to continued ischemic injury following any  insult, the extension phase of  
 
AKI. The structural alterations that occur in the endothelial cell following  
 
an  ischemic  injury  have  been  partially elucidated and help  explain  the  
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functional  changes  that  occur  during this  injury  process.  The  baseline  
 
structure  of  the  endothelial  cell  is  maintained  by a  network  of  protein 
 
filaments  that  make  up the  cytoskeleton.  Actin filament  bundles,  which 
 
have been shown to shrink in the setting of ATP depletion. The assembly 
 
actin desaturasing factor/cofilin (ADF.  )  family of  proteins  is  known to  
 
regulate  actin dynamics  and  play  a  role  in the  changes  to the  actin 
 
cytoskeleton  during ischemia  under  ATP-depleted conditions  (such  as  
 
ischemia).  Modulation  of  the  ADF/cofilne  mediated ADF/cofiline  has  a  
 
concentration-dependent  effect  on changes  to the  actin cytoskeleton 
 
changes  to  the  actin  cytoskeleton  in ischemic  endothelial  cells  has  
 
potentially important  therapeutic  implications  for  ischemic  AKI 17,  and  
 
may have applications in other organ systems as well.  
 
The Renal Tubular Epithelial Cell  
 
 
 
      Following  are  the  most  obvious  cell  type  injured in  ARF  that  is  the  
 
renal  tubular  epithelial  cells,  which are  visible  on  routine  urine  analysis  
 
and   light  microscopy  as  well  as.  Injury  and loss  of  epithelial  cells,  
 
through  necrosis  or  apoptosis  can  lead to loss  of  kidney  function  and  
 
apparent  drop in  GFR  through  processes    of  glomerular  filtrate  and  
 
tubular  obstruction.  The  renal  tubular  cell  has  a    marked   ability to  
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recover  from  an ischemic  injury.  The  tubular  epithelial  cell  progresses  
 
through a series of  structural  changes that finally leads to restoration of  
 
normal  structure  tubular  lumen,  and  the  remaining viable  cells  
 
dedifferentiate  and proliferate  leading  to  final  reformation  of  normal  
 
epithelium. The initial and function. These steps include an initial loss of  
 
cell polarity and brush border, which contributes to altered solute tracking   
 
Some  cells  die  and are  sloughed  into  the  insult  to  the  tubular  epithelial  
 
cell This structural change in the cell leads to the formation of membrane  
 
dependent depletes cellular ATP, which, in turn, leads to disruption of the  
 
basal actin cytoskeleton  in a  fashion that mirrors the changes  in  vascular  
 
endothelial  cells  in  thekidney.  vesicles  or  blebs  that  can  either  be  
 
secreated into the  tubular  lumen as  part  of  the  cellular  debris  leading  to  
 
cast formation and tubular obstruction 
 
 
 
 
 
 
 
COURSE OF ACUTE TUBULE NECROSIS  
 
 
 
Initiation, maintenance phase, and recovery phases are the three phases of   
 
ATN  .18  The  initiation  phase  is  the  period  when patients  are  exposed to  
 
the  ischemia  or  toxins  and parenchymal  renal  injury is  evolving but  not  
 
yet  established.  Acute  tubular  necrosis    is  potentially preventable  during 
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this  period,  which  may  last  hours  to days.  The  maintenance  phase  is  the  
 
most important phase in the prognosis of acute kidney injury . avoidance  
 
of toxin and the toxic products reperfusion , all had a important role in the  
 
outcome  of  acute  kidney  injury  .  interventions  in  the  form  of  drugs  says  
 
asmotic  diueretics,  loop diuretics,  control  of  diabetic  mellitus  and  
 
hypertension all influence the recovery phase. In case of recovery phase it  
 
is  assessed by  adeguate  urinary  output,  decrease  in  urea  ,creatinine,  
 
symptomwise improvement .  Occasionally, diuresis may be inappropriate  
 
and  excessive  if  recovery of  tubule  reabsorptive  processes  lags  behind  
 
glomerular filtration.  
 
 
 
COMPLICATIONS OF ACUTE KIDNEY INJURY  
 
 
 
Intravascular  volume  overload is  an  almost  inevitable  consequence  of  
 
diminished salt and water excretion in AKI and may present clinically as  
 
mild hypertension,  increased jugular  venous  pressure,  bibasilar  lung 
 
crackles,  pleural  effusions  or  ascites,  peripheral  edema,  increased body 
 
weight,  and life-threatening  pulmonary edema.  Moderate  or  severe  
 
hypertension is  unusual  in ATN  and  should suggest  other  diagnoses  
 
Hypervolemia  may  be  particularly troublesome  in  patients  receiving 
 
multiple  intravenous  medications,  sodium  bicarbonate  for  correction  of  
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acidosis,  or  enteral  or  parenteral  nutrition.  such  as  hypertensive  
 
nephrosclerosis,  glomerulonephritis,  renal  artery stenosis,  and  other  
 
diseases  of  the  renal  vasculature.   19Excessive  water  ingestion or  
 
administration  of  hypotonic  saline  or  isotonic  dextrose  solutions  can 
 
trigger  hyponatremia,  which,  if  severe,  may  cause  cerebral  edema,  
 
seizures, and other neurologic abnormalities.20 
 
 
 
agnesium,  
 
 
 
magnesium-containing 
 
 
 
laxatives,  
 
 
 
or  
 
 
 
antacids).  
 
Hypomagnesemia  occasionally complicates  nonoliguric  ATN  associated  
 
with  cisplatin or  amphotericin B  and,  as  with  hypokalemia,  probably 
 
reflects injury to the thick ascending limb of loop of Henle, the principal  
 
site  for  Mgreabsorption.  Hypomagnesemia  is  usually  asymptomatic  but  
 
may occasionally  be  manifest  as  neuromuscular  instability,  cramps,  
 
seizures, cardiac arrhythmias, or resistant hypokalemia or hypocalcemia.  
 
 
 
Mild  gastrointestinal  bleeding is  common  (10%  to 30%)  and is  usually 
 
due to stress ulceration of gastric or small intestinal mucosa.Alterations in 
 
neurologic  function  may  reflect  the  onset  of  the  uremic  syndrome,  
 
metabolic  complications  of  AKI,  impaired excretion  of  prescribed  
 
neuropsychiatric  medications,  or  primary neurologic  disease  including 
 
TTP.  
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MANAGEMENT OF ACUTE KIDNEY INJURY  
 
 
 
The  goals  of  management  of  AKI  encompass  the  need  to prevent  death,  
 
ameliorate  metabolic  and extracellular  volume  complications,  and  
 
preserve  renal  function  so as  to prevent  the  development  of  chronic  
 
kidney disease.  
 
 
 
Prerenal Acute Kidney Injury 
 
 
 
Prerenal  AKI  is  reversible    on  restoration  of  renal  perfusion.  The  
 
replacement  fluids  varies  depending on the  source  of  fluid  loss    for  
 
treatment of hypovolemia.  packed RBCs is used for hypovolemia caused  
 
by  hemorrhage  .it  is  used only  if  the    if  the  patient  is  hemodynamically 
 
unstable or  if the  hematocrit  is  low. isotonic saline alone can be used in 
 
the  absence  of  active  bleeding or  hemodynamic  instability..  Recent  
 
critical  reviews  of  RCTs  comparing crystalloid with  colloid replacement  
 
for  resuscitation  in  critically  ill  patients  conclude  that  the  routine  use  of  
 
colloids may be associated with an adverse outcome and is not justified. 21 
 
Colloid solutions should be used only sparingly, with regular  monitoring 
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of renal function and the risk of hyperoncotic renal failure  minimized by 
 
the  concomitant  use  of  appropriate  crystalloid solutions.  In case  of  loss  
 
due to  urinary or gastrointestinal loss vary hypotonic fluids can be used.  
 
in this case  initial replacement is best achieved with hypotonic solutions  
 
(e.g., 0.45% saline), and subsequent  fluids is depends on  composition of  
 
excreted  or  drained fluids.  Electrolytes    should be  monitored  in  all  
 
subjects.  K+  supplementation  is  required   in case  of  hypokalemia  
 
occurring  during treatment of metabolic acidosis  
 
 
 
Intrinsic Acute Kidney Injury 
 
 
 
Optimization  of  cardiovascular  function  and intravascular  volume  is  the  
 
single  most  important  maneuver  in  the  management  of  intrinsic  AKI.  
 
Aggressive  management  of  fluid loss  in  case  associated with major  
 
trauma can prevent the major consequenceof  intrinsic acute kidney injury  
 
.22.Sepsis related AKI is a common clinical presentation and is associated  
 
with  mortality  rates  as  high  as  80%.    Volume  depletion  has  been 
 
identified as  a  risk factor  for  nephrotoxic  ATN  induced by radiocontrast  
 
material.]  Restoration  of  volume  prevents  the  development  of  
 
experimental and human ATN in many of these settings. The importance  
 
of  maintaining euvolemia  in  high-risk  clinical  situations  has  been 
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demonstrated  most  convincingly with contrast  nephropathy,  in  which 
 
close attention to intravascular  volume status ensures a low  frequency of  
 
AKI.  
 
 
 
 Some drugs like loop Diuretics or other class of diuretics should be used  
 
in  caution  .  similliarly  drugs  like    NSAIDs  ,  ACE  inhibitors,  and other  
 
vasodilators  should be  used with  caution.,  because  they  may  convert  
 
prerenal ARF to ischemic ATN and sensitize such patients to the actions  
 
of nephrotoxins. Careful  monitoring of circulating drug  levels appears to  
 
reduce  the  incidence  of  ARF  associated with  aminoglycoside  antibiotics  
 
or  calcineurin  inhibitors  Interestingly,  the  antimicrobial  efficacy of  
 
aminoglycosides appears to persist in tissues even after the drug has been 
 
cleared from the circulation. Also, there is convincing evidence that once- 
 
daily dosing with these  agents  affords  equal  antimicrobial  activity  and  
 
less  nephrotoxicity than  conventional  regimens. 23The  use  of  lipid- 
 
encapsulated formulations  of  amphotericin B  may  offer  some  protection 
 
against  renal  injury.  Several  other  agents  are  commonly  employed to  
 
prevent  AKI  in  specific  clinical  settings.  The  drug  called Allopurinol    is  
 
useful  for    acute  urate  nephropathy;  but  many occasional  patients  
 
receiving  allopurinol  still  develop AKI,  probably  by    toxic  actions  of  
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hypoxanthine  crystals  on  tubule  function.24.so nowadays  commonly the  
 
use of recombinant urate oxidase  called raburicase at a dose of  0.05–0.2 
 
mg/kg  should be  considered.  Lets  see  how  it  acts    Raburicase  promotes  
 
the  degradation  of  uric  acid to allantoin  .  so it    proven  efficacy  both  as  
 
prophylaxis  and treatment  for  acute  uric  acid-mediated tumor  lysis  
 
syndrome.  Also note  that ]  In  oligoanuric  patients,  prophylactic  
 
hemodialysis to remove excess uric acid is important.  
 
 
 
 A  newer  drug  called Amifostine,  known  to be  an    an  organic  
 
thiophosphate,  has  been  used to to ameliorate  cisplatin nephrotoxicity  in 
 
patients  with  solid organ  or  hematologic  malignancie.  a  good droug 
 
named dimercaprol,  a  chelating  agent,  may  prevent  heavy  metal  
 
nephrotoxicity.  Ethanol    by  dumping the  effects  of    ethylene  glycol  
 
metabolism  to oxalic  acid and other  toxic  metabolites  but  has  been 
 
superceded by  the  introduction  of  fomepizole,    known  fo its  active  
 
effective  alcohol  dehydrogenase  inhibitor  that  decreases  production of  
 
ethylene  glycol  metabolites  and therefore    prevents  the  development  of  
 
renal injury.  
 
 
 
Specific Therapies  
 
For  the  past  2 decade  there  has  been  extensive  investigation into  the  
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pathogenesis  of  AKI  using experimental  animal  models  and   also  
 
commonly  by  the  cultured cells.  These  studies  have  led to substantial  
 
advances  in our  understanding of  the  mechanisms  that  could potentially 
 
play a role iof some drugs in  ATN in humans. This information has led to  
 
an  exciting  array  of  potentially  difficult  targets  for  the  treatment  of  this  
 
common and serious disease. However, a number of interventions shown 
 
to be  effective  in  treating  AKI  in  animals  have  failed to be  effective  in 
 
humans  with  ATN.  There  are  so many possible  reasons  for  lack  of  
 
success  in  translating  therapeutic  successes  for  AKI  from  out  of  scene  
 
.We  lack adequate  information  regarding  the  pathology of  ATN  in 
 
humans  in  the  current  era,  because  there  has  been  a  lack of  systematic  
 
studies  in this  area  for  many years.  It  is  possible  that  human  tissue,  
 
subjected to conventional  histologic  stains    would facilitate  the  
 
identification of those patients most likely to response to treatment.  
 
Dopamine 
 
 
 
 (1 to 3 mg/kg/min)    is  the  renal  doseof    dopamine  has  been  widely 
 
advocated for  the  management  of  oliguric  AKI. 24Note  that    in 
 
experimental animals and healthy human volunteers, renal dose dopamine  
 
increases renal blood flow and, albeit to a lesser extent, GFR. It was well  
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estabilished that  r  enal  dose  dopamine  has  not  been  demonstrated to  
 
prevent or alter the course of ischemic or nephrotoxic ATN in  controlled  
 
clinical trials. 25But what to do  the available evidence would suggest lack  
 
of  efficacy.  Also note  that    dopamine,  even  at  low  doses,  is  potentially 
 
toxic in critically ill patients and can induce tachyarrhythmias, myocardial  
 
ischemia, hypotension  extravasation necrosis among other complications.  
 
From  this  it  was  clear  that    the  routine  administration  of  dopamine  to  
 
patients  with  oliguric  AKI  is  not  justified based on  the  balance  of  
 
experimental and clinical evidence.  
 
 
 
Fenoldopam 
 
 
 
Fenoldopam  is  a  new  drug commonly used nowadays  as  a    selective  
 
postsynaptic  dopamine  agonist    mainly of  D1-receptorsthat  mediates  
 
more  potent  renal  vasodilatation  and natriuresis  when  compare  to   
 
dopamine]  However,  it  also promotes  hypotension  by  decreasing 
 
peripheral  vasculature  resistance.  In  clinical  trails  early  results  suggest  
 
that    positive  results  from  small  studies  suggested a  possible  benefit  
 
renoprotective  effect  of  fenoldopam  in many clinical  situation.  But  u 
 
should also note  that  ,  a  subsequent  larger  randomized trial  comparing 
 
fenoldopam to standard hydration  in patients of angiographic procedures  
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found no benefit. Finally  in a large RCT, fenoldopam administration did  
 
not  reduce  mortality  or  the  need for  renal  replacement  therapy  in  ICU  
 
patients presenting with early ATN.  
 
 
 
 
 
 
Natriuretic Peptides 
 
 
 
Coming to the  ANP  it  is    a  28-amino acid  polypeptide  synthesized in 
 
cardiac  atrial  muscle.  ANP  augments  GFR  by  triggering afferent  
 
arteriolar  vasodilatation  and increasing  GFR  .  In  addition,  ANP  also  
 
inhibits  sodium  transport  and lowers  carbondioxide  and bicarbonate    
 
requirements  in  several  nephron segments.  Synthetic    preparation   of  
 
ANP have shown promise in the management of ATN in the  presence of  
 
laboratory  setting.  To date,  this  promise  has  failed to  translate  into  
 
clinically  inadvesible    benefit  and also note  that    large  multicenter,  
 
prospective,  randomized placebo controlled trial  of  a  drug  called   
 
anaritide, a synthetic analog of ANP, failed to show clinically significant  
 
improvement  in dialysis-free  survival  or  overall  mortality  in  ATN.[615] 
 
Subgroup analysis is failed to  suggested an improvement in dialysis-free  
 
survival  in  treated patients,  but  this  was  not  confirmed in  a  subsequent  
 
prospective  trial  of  patients  with  oliguric  AKI.    a  non  marketable  drug   
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Ularitide   is a natriuretic pro-ANP  fragment produced within the kidney.  
 
In a small randomized trial,  it is also known that ularitide did not reduce  
 
the need for dialysis in patients with AKI.  
 
 
 
 
 
 
Loop Diuretics 
 
 
 
Using of high-dose intravenous diuretics to individuals with oliguric AKI  
 
is commonly practiced nowadays everywhere.  617] Although this strategy 
 
may minimize  fluid overload,but    there  is  no evidence  that  it  alters  
 
mortality  or  dialysis-free  survivalin majority of  patients  .it  was  also  
 
shown  that    Some  retrospective  analyses  have  reported an  increased risk  
 
of  death    in  subgroup of  patients  and poor  recovery  of  renal  function  in 
 
patients  treated in  this  manne.  In  case  of    a  recent  large  RCT,  high-dose  
 
intravenous  loop  diuretics    augmented  urine  output  but  did  not  change   
 
the  outcome  of  established AKI.[619]  Given  the  risks  of  loop diuretics  in 
 
AKI,  including irreversible  ototoxicity and  exacerbation  of   
 
ofexixtingAKI,so it  should be  keep in  mind that    their  use  should be  
 
restricted to the conservative management of volume overload .  
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Mannitol 
 
 
 
There  is  no enough  trails    to support  the  routine  administration  of  
 
mannitol  to oliguric  patients.  However  it  was  known  that  when 
 
administered to severely  oliguric  or  anuricpatients,it    may  trigger  
 
expansion  of  intravascular  volume  and pulmonary edema  but    severe  
 
hyponatremia  owing  to shift  of  water  from  the  intracellular  to the  
 
intravascular space is a common problem .26 
 
 
 
 In  case  of  Glomerulonephritis  or  vasculitis  corticosteroids  can  be  used .  
 
in  some  rare  situations    caused by  other  intrinsic  renal  diseases  such  as  
 
acute  it  may  also shown  that  it    may  respond to alkylating agents,  and  
 
plasmapheresis,  Corticosteroids appear to fasten  remission in some cases  
 
of      interstitial  nephritis.  Also known  that  Plasma  exchange  is  useful  in 
 
treatment of TTP and possibly sporadic hemolytic uren=mic syndrome in 
 
adults. The role of plasmapheresis in the drug-induced  microangiopathies  
 
is  not    clear,  and removal  of  the    agent  is  the  most  important  initial  
 
therapeutic method. HUS in children secondary to diarrhoea  is should be   
 
managed conservatively  and   supporting evidence  exists  suggesting  that  
 
early antibiotic therapy may actually promote the development of HUS in 
 
such  patients.    many  RCP  studies  found that    plasmapheresis  may be  of  
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benefit in ARF due to cast nephropathy in case of myeloma.  Clearance of  
 
circulating  light  chains  with  concomitant    drugs  like  hydroxyurea    to  
 
decrease the rate of production had been postulated to reverse renal injury 
 
in  patients with circulating light chains,  multiple  myeloma  and AKI.  A  
 
recent    largeRCT  compared plasma  exchange  and     chemotherapy  with 
 
chemotherapy  alone.  The  study  did not  demonstrate  improvement  with 
 
plasma  exchange  when  comparing with the  death  ratio   ,  dialysis  
 
dependence, or GFR less than 30 mL/min at 6 months, and its routine use  
 
in this setting can no longer valuable.  
 
 
 
 Controlling of  hypertension  is  very  very  important  in certain situations  
 
like  preeclampsia,  malignant  hypertension,  and  hypertension in  case  of  
 
chemotheraphy indused like cyclosporine .  
 
 
 
Management of Complications  
 
 
 
Metabolic  complications  such  as  hyperkalemia,  hyperphosphatemia,  and  
 
metabolic  acidosis,  intravascular  volume  overload,  are  almost  occur    in 
 
oliguric  AKI,  and preventive  measures    must  be  taken  from  the  time  of  
 
diagnosis.Prescription  of  nutrition  should be  offered to meet  caloric  
 
requirements  and minimize  catabolism.  In  addition,  doses  of  drugs  
 
excreted through the kidney must be adjusted  according  degree of renal  
 
41  
 
 
 
 
diseases.  
 
 
 
 
After  correction  of  intravascular  volume  deficits,  salt    intake  should be  
 
adjusted to match losses  such as urinary, gastrointestinal, drainage sites,  
 
insensible  losses.By    restriction  of  salt  and water  intake  and by  use  of   
 
furosemide    intravascular  volume  overload can  usually be  managed .  
 
However    no proven  rationale  for  routine  administration  of  furosemide  
 
with AKI other than to treat this complication. In the volume-overloaded  
 
patient,  high doses  of  loop diuretics    or  sequential  thiazide  and loop  
 
diuretic  may  be  required if  they  fail  to respond to conventional  doses.  
 
Diuretic  therapy should be  discontinued in resistant  patients  to  avoid  
 
complications  presenting  with    ototoxicity.  Caution  should  be  exerted  in 
 
the use of  drugs  that require an obligate sodium and fluid load.  dialysis  
 
may be required for removal of volume when conservative measures fail.  
 
Hyponatremia    are  corrected by  restriction  of  water  intake  and  
 
hypernatremia  are  corrected by     treated by  administration of  water,  
 
hypotonic saline solutions, or hypotonic dextrose fluids.  
 
 
 
 Hyperkalemia of mild severity says <5.5 mEq/L) should be managed by 
 
restriction of  dietary potassium  intake  and  elimination  of  potassium  rich 
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foods  and potassium-sparing drugs  .  Moderate  hyperkalemia  said to be  
 
(5.5 to 6.5 mEq/L)  in  patients  without  clinical  or  ecg  evidence  of  
 
hyperkalemia  can  usually be  controlled by administration  of  K+-binding 
 
ion exchange  resins  commonly used sodium  polystyrene  sulfonate    at  a  
 
dose of 15 to 30 g every 3 or 4 hours  with sorbitol  at a dose of 50 to 100  
 
mL of 20% solution by mouth or rarely  as a retention enema. Furosemide   
 
increase  K+  excretion  in  diuretic-responsive  patients.  Emergency 
 
treatment  is required when serum  K+  values greater than 6.5 mEq/L and  
 
also in    patients  with  ecg    abnormalities  or  clinical  features  of  
 
hyperkalemia.    In this  case  Intravenous  insulin   glucose  solutions   
 
promote  K+ shift into cells  in 30   minutes, a benefit that  lasts for several  
 
hours.  Sodium  bicarbonate    also promotes  rapid onset  less  than  15  
 
minutes, duration 1 to 2 hours  shift of K+ into the intracellular space as  
 
does  
 
done  by nebulized  (5–10  mg)  albuterol.  Sodium  
 
polysterenesulfonate  and  sodium  bicarbonate  have  sodium  load;  these  
 
compounds  should be  used carefully   foroliguric  patients  to avoid  
 
intravascular volume overload and in case of  pulmonary edema. calcium  
 
gluconate  (10 mL  of  10%  solution intravenously  over  10 minutes  
 
antagonize the cardiac and neuromuscular  effects of hyperkalemia and is  
 
a emergency temporizing measure in case of whereas other agents reduce  
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serum  K+  concentration.  Hemo or  peritoneal  d ialysis  is  indicated if  
 
hyperkalemia is resistant to all those  measures.  
 
 
- 
Metabolic acidosis  usually  not require treatment unless the serum HCO3 
 
concentration falls below 15 mEq/L. severe acidosis can be corrected by 
 
either  oral  or  intravenous  bicarbonate  administration.  Initial  rates  of  
 
replacement  should be  depends  on  the    estimates  of  HCO3-  deficit  and  
 
adjusted thereafter based on  to serum levels. Patients should be watch for  
 
complications  of  bicarbonate    including  metabolic  alkalosis,  electrolyte  
 
imbalance  and   volume  overload,  and  pulmonary  edema.  of  oral  
 
administration  of      phosphate    Hyperphosphatemia  can  usually  be  
 
controlled by  restriction  intake  and administration  of  agents  such  as  
 
aluminum hydroxide, calcium carbonate  that reduce absorption of PO43- 
 
from  the  gastrointestinal  tract  and also by    oral  administration  of  
 
phosphate    Hypocalcemia  does  not  usually  require  treatment  until  it  is  
 
severe,  as  may occur  in  patients  with rhabdomyolysis    or  after  
 
administration  of  bicarbonate.  Hyperuricemia  is  usually not  severe    in 
 
ARF  and does not require specific intervention.  
 
 
 
Physicians,  nurses,  and dietitians  play  a  role  in    nutritional  management  
 
in  patients  with  AKI  requires  close  collaboration  among.  Patients  with 
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ARF  represent  a    dispersed group and   individualized nutritional  
 
management  is  required,  especially  in critically  ill  patients  on  renal  
 
replacement therapy in whom protein catabolism is more.27 .  Diet is very 
 
important in case of management of acute kidney injury. Because the loss  
 
of  nitrogenous  products  can  cause  decrease  in  lean  body  mass  and  
 
subsequent  malnitrtion and its  consequences.  If  the  duration of  renal  
 
insufficiency is likely to be small  and the patient is not much  catabolic,  
 
then dietary  protein should  be  restricted  t  is  less.  Catabolic  patients,  in 
 
whom    on  continuous  renal  replacement  therapy,  may  receive  up to 1.4  
 
mg/kg body weight/day.  Also the Total caloric intake should not exceed  
 
35kcal/kg  body  weight/day  .  The  enteral  route  of  nutrition  is  preferred,  
 
because  it  prevents    the  morbidity  associated with  parenteral  nutrition 
 
while providing support to intestinal function. Management of nutrition is  
 
much  easy in nonoliguric patients and after commencement  of dialysis..   
 
Water-soluble  vitamin supplementation  is  advised with  the  exception  of   
 
some , which can, promote urinary oxalate excretion and stone formation.  
 
 
 
Anemia  may  necessitate  blood transfusion  or  administration  of  
 
recombinant  human  erythropoietin if  severe  .    Uremic  bleeding rarely   
 
usually  responds  to desmopressin,  correction  of  anemia,  estrogens,  or  
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dialysis. Renal Dosage adjustment is needed  of drugs that are excreted by 
 
the  kidney. ] Gastric stress  ulcer prophylaxis  is  commonly not  indicated  
 
unless  the  patient  is  intubated.    Febrile  patients  must  be  investigated  
 
aggressively for infection and may require treatment with broad-spectrum  
 
antibiotics while awaiting results  of specific organisms. Meticulous care  
 
of intravenous  needles , Foley catheters, and other  devices is mandatory.  
 
It  is  not  shown  that  prophylactic  antibiotics  have  not  been  shown  to  
 
reduce the incidence of infection in these high-risk patients.  
 
 
 
Indications and Modalities of Dialysis  
 
General Comments 
 
 
Dialysis  does  not  fasten    recovery  from  AKI.28  but    Initial  studies  
 
suggesting  that  early  dialysis  therapy  improved prognosis  for  patients  
 
with  AKI  have  but  it  not proved not been confirmed. Similarly, there  is  
 
no results    on  the  optimal  renal  replacement  therapy  in AKI.  The  
 
preferred mode  of  renal  replacement  therapy is  an  area  of  still  research 
 
one.  The  claimed superiority  of  the  continuous  renal  replacement  
 
techniques    also remains  unproven.  Neither  are  there    guidelines  on  the  
 
initiation  of  dialysis  in  AKI.  following  are  the    Absolute  indications  for  
 
the  commencement  of  renal  replacement  therapy   say  symptomatic  
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uremia    like  asterixis,  pericardial  rub,  encephalopathy  and   acidosis,  
 
hyperkalemia,  or  volume  overload that  proves  refractory  to medical  
 
management. However, in clinical practice, most physician  initiate renal  
 
replacement therapy (RRT) before the onset of overt  metabolic disorders   
 
when  the  need for  renal  support  appears  is  not  there  .  The  choice  of  
 
dialysis  modality  is  often  guided  by  the  resources  of  the  health  care  
 
institution, the technic opinion of the  physician and the clinical status  of  
 
the patient.  
 
 
 
Peritoneal Dialysis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peritoneal  dialysis  in  AKI  is  done    through  a  temporary  intraperitoneal  
 
catheter.  With  the  development  of      the  slow  continuous  blood  
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purification therapies, there  is   a decline  in the  use  of  peritoneal dialysis  
 
in  the  acute  setting.29    It  is  still  used in  the  treatment  of  AKI  in  regions  
 
where  access  to acute  intermittent  or  slow  continuous  hemodialysis  is  
 
very  low.  Peritoneal  dialysis  has  the  advantage  of  being  relatively 
 
portable,  thus  facilitating  its  use  in  remote  or  resource-  timed areas.  
 
Systemic hypotension is typically avoided, and other benefits include the   
 
lack of  systemic  anticoagulation and need for  angioaccess  as  soon  As   
 
possible  Solute  clearance  and control  of  metabolic  disturbance  in 
 
critically ill  patients  may  be  inferior  to  continuous  veno-veno  
 
hemofiltration,  and this  has  been  associated with  an  adverse  outcome  
 
inAKI  secondary to infection.    Other  drawbacks  include  the  risk of  
 
visceral injury during catheter placement and peritonitis can occur .  
 
 
 
Acute Intermittent Hemodialysis  
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 Before  the  invent  of  hemodialysis,  renal  replacement  therapy was  
 
commonly done. It was done in alternate days for 2 to 3 hours each time.  
 
Here  double  lumen  catheter  is  passed through  either  jugular  vein  or  
 
femoral  vein .    Subclaviancanulation  offers  an  alternative  but  it  causes  
 
high rates of venous stenosis and is best avoided.30 To note is the Femoral  
 
vein catheterization  is  technically easy  and relatively free  of  
 
complications. It  is useful  in patients who cannot tolerate the  left  lateral  
 
position or who require only a short treatment course (e.g., removal of an 
 
exogenous  toxin).  Jugular  lines  are  preferred for  more  prolonged  
 
treatment courses, but with careful  nursing management,  it  is possible to  
 
maintain  a  femoral  line  in  the  bedbound patient  without    causing  a   
 
significant  excess  infection  risk.    The  choice  of  membrane  used during 
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dialysis also  have an effect on outcome. Several, although not all, RCTs  
 
indicate  that  the  maintenance  phase  of  ATN  is  significantly shorter  by 
 
using synthetic dialysis membranes (e.g., polysulphone, polyacrylonitrile)  
 
than  with    other  membranes.  However,  systematic  reviews  of  the  
 
literature  have  failed  to    demonstrate  a  benefit  of  synthetic  over  more  
 
modern substituted  membranes.  
 
 
 
During acute  intermittent dialysis  Anticoagulation  with  heparin    must be  
 
used for    preventing  thrombosis  of  the  extracorporeal  circuit.    Routine  
 
bedside  assesement  of the activated clotting time (ACT) allows heparin 
 
dosage adjustment as required to maintain a normal  baseline  value.  Also  
 
note  that    Heparin-free  dialysis  can  be  performed in patients  with   
 
hemorrhagic  complications.  This  involves  coding    the  dialyzer  with  a  
 
heparinized solution  (3000U/L)  and setting  the  blood flow  rate  at  least  
 
200 to 250  mL/min. A periodic saline rinse  also should be used  which 
 
should be  done    every  30 minutes  to prevent  the  clotting  in  the  
 
extracorporeal  circuit.  If  heparin-induced  thrombocytopenia  (HIT)  is  a  
 
concern then the  heparin coating   should be  avoided.  Other  
 
anticoagulation techniques  include  the  usage    of  a  single  bolus  of  low- 
 
molecular-weight  heparin  at  the  start  of  dialysis.Less  used anticoagulant  
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strategies  include    regionalheparinization  with  protamine  administration 
 
in  the  venous  return  line,  regional  citrate  ,    continuous  prostacyclin 
 
infusion, and use of direct thrombin inhibitors: says hirudin,  lepirudin .   
 
 
 
. Intradialytic hypotension is common in patients undergoing  this type of  
 
hemodialysis. Hypotension impairs solute clearance and the efficiency of  
 
dialysis.  In addition it    can  further  compromise  renal  perfusion  and  
 
exacerbate tubular necrosis . Intradialytic hypotension is typically caused   
 
by excessive fluid removal during ultrafiltration.  The latter, in turn, may 
 
occur if there is volume overload  if the fluid removed is not matched by 
 
flux  of  fluid into the  intravascular  space  from  interstitial  and other   
 
compartments, if the volume of fluid removed is more , or if the patient's  
 
compensatory  responses  are  less  as  a  result  of  microvascular  disease  or  
 
vasodilatatory medications say  nitrates, and antihypertensive medication.  
 
Hypotension    is  a  problematic  in  critically  ill  patients  with  ATN  and  
 
concurrent  sepsis,  hypoalbuminemia,  malnutrition,  or  large  third-space  
 
fluid   losses.  Management  of  intradialytic  hypotension  requires  careful  
 
assessment  of  intravascular  volume,  by  invasive  intra  catheter   
 
monitoring,  if  necessary;  usage  of    realistic  ultrafiltration  targets;  and  
 
close  observation  for  tachycardia  or  hypotension  during  dialysis.  The  
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immediate  management  of  hypotension  involves  the  discontinuation  of   
 
dialysis , placing the patient in the Trendelenburg position, and the rapid  
 
infusion of normal saline.  
 
 
 
The  dialysis  disequilibrium  syndrome  is  acommon complication  or  side  
 
effects  of  hemodialysis  .  it  is  because  of  cerebral  s[edema.  The  cause  of  
 
cerebral  edema  is  not  known .  however  it  was  hypothesized that  sudden 
 
removal of solutes  can cause the protective substances in the brain to be  
 
removed and cause cerebral edema as a consequence.31  It can be slowly 
 
overcome  with the  application of  slow  rate  hemodialysis  in the  starting 
 
period.  The  precise  prescription of  dialysis  to achieve  this  outcome   
 
depends  on such  variables  as  membrane  size,  blood  flow  rate,  and  
 
duration of treatment. Typically, this will involve an initial treatment time  
 
of  approximately3   hours  with a  blood flow  rate  of  300 to 350 mL/min.  
 
Isolated ultrafiltration can continue for a longer period if volume removal  
 
is the critical management issue.   
 
 
 
Once the patient is established on dialysis, the optimal dose of dialysis is   
 
depends  on many factors  .  The  standard protocol    for  dialysis  adequacy 
 
using  intermittent  hemodialysis  in  ARF  is  not    defined.  Of  note,  the  bad  
 
nutrition state observed in ill patients may justify large dialysis dose .  In 
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patients  with AKI,  the  change    between delivered versus  prescribed  
 
hemfiltration dialysis  dose  may be  significant    change  to  hemodynamic  
 
instability like filter clotting and inadequate vascular access, among other  
 
reasons.  A  randomized   trial  of  daily  versus  alternate-day  hemodialysis  
 
suggested  a  significant  mortality   in patients  receiving daily dialysis.  
 
According to this  study   daily hemodialysis  offer  better  uremic  control  
 
while  facilitating  more  intensive  catabolic      support  without  additional  
 
hemodynamic compromise and is now considered the standard of care.  
 
 
 
The  potential  importance  of  dialysis  membrane    as  a  determinant  of  
 
outcome  in  ATN  has  been discussed before  .  Occasionally  robust  
 
complement  and leukocyte    migration by  cellulosic  membranes  is  
 
followed by leukocyte attachment  in the lungs, hypoxemia, dyspnea, and  
 
back pain; this is also termed the  the first use syndrome.  More indolent   
 
anaphylactoid reactions  were    seen  in  the  past  as  a  result  of  
 
hypersensitivity  to ethylene    used to sterilize  the  dialysis  circuit.    These  
 
reactions  are  now    not  common as  a  result  of  changes  in commercial  
 
sterilization techniques  and the  routine  washing   of  the  dialysis  circuit.       
 
Patients  who  receive  concomitant  ACE  inhibition  can rarely have  
 
anaphylactoid reactions  are  observed in  patients  dialyzed  on  AN60  
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synthetic membranes . AN69 activates the kallikrein system and promotes  
 
bradykinin   synthesis  .  as  we  all  know    the  breakdown of  bradykinin is  
 
inhibited by  ACE  inhibition  so that  in  combination,  ACE  inhibitors  and  
 
an AN69 membrane accentuate the circulating bradykinin levels.  
 
 
 
Continuous Renal Replacement Therapy 
 
 
 
As  we  know  most  patients  in  acute  tubular  necrosis  are    ill,  
 
hypercatabolic,  and hemodynamically  unstable.  They  frequently  have  
 
large  obligate  fluid requirements,  although    on  intravenous  medication 
 
and parenteral  supplements . In this condition , filtration of large volumes  
 
of  plasma  over  a  relatively  short  period  by  acute    hemodialysis  may 
 
induce  circulatory  compromise.  Even  if  tolerated ,  acute  intermittent  
 
hemodialysis  may  not  achieve  adequate    filtration or  solute  clearance  to   
 
avoid pulmonary  edema    and   uremia,  and  continuous  renal  replacement  
 
therapy  (CRRT)  may  be  more    reasonable  .  Hemofiltration  was  first  
 
described in 1979 for the management of refractory edema. For  the past 3 
 
decades  have  yielded a  variety  of  slow  continuous  dialytic  therapies.   
 
Whereas the various techniques differ  in their technical detail, they share  
 
several    features  such  as  relative  simplicity  of  operation,  the  ability  to  
 
remove  large  volumes of  fluid with minimal  hemodynamic compromise,  
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and the  capacity to control  uremia  and electrolyte  and acid-base  
 
abnormalities with minimal change  of plasma osmolality.   
 
 
 
OUTCOME  
 
 
 
The    mortality rate  approximates  50%      among patients  with  intrinsic  
 
AKI.    It  was  changed in the  last  two  decades    because  of  active  
 
management  protocols  This  lack of  improvement  in outcome,    may  be  
 
more apparent than real and reflect a reduction in the percentage of   AKI  
 
in  addition  with  an    with  an  increase  in  AKI  complicating the  multiple- 
 
organ  dysfunction.    When    combined   with  the  current  trend for  more  
 
aggressive surgical and intervention  in the aged population, these factors  
 
probably  mask an  improvement  .  Mortality  rates  differ  markedly 
 
depending on the cause of AKI:  approximately 10% in obstetric patients,  
 
20%  in toxin-related AKI,  and 50%  to 80%  in patients  with 
 
sepsis..Although it  was  once  held that  the  provision  of  effective  renal  
 
replacement  strategy largely change  the prognostic import of an episode  
 
of AKI, more recent observations clearly demonstrate that this is not case  
 
.  and that  all  too often,  the  development  of  AKI  directly  contributes  to  
 
poor  patient  outcomes.Following are    factors  causing    poor  prognosis  
 
include  male  sex,  advanced age,  oliguria  ,  and a  rise  in  the  serum  
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creatinine  value  of  greater  than  3 mg/dL,  factors  reflecting more  severe  
 
renal injury and failure of other  systems.  
 
 
 
 According to recent study even mild decreases in renal function are now  
 
recognized as  being  associated with  worse  patient  outcomes.  Inthis  is  
 
evidenced  by a  study of  contrast  nephropathy  subjects  whose  serum  
 
creatinine  rise    by  at  least  20%  to 3 mg/dL    and was  associated with a  
 
greater  than  fivefold increase  in  mortality  even  after  adjustment  for  
 
confounding factors .  Although it was not clear with the use of bivarient   
 
levels  of  renal  function, to what extent  the relationship is  influenced  by 
 
the subjects with  more extreme depression  in  function.  A study of 6000  
 
general ICU patients  found significant association between early degrees  
 
of  AKI  as  assessed by wifle    score  and  mortality.  Eventhough   with  the  
 
use  of  renal  replacement  therapy,  mortality remains  high as  compared  
 
with those with stable  independent renal function.  
 
 
 
In addition to its clinical  importance , ARF prolongs hospital stays and is  
 
associated with  more    increased medical  expenditure.  The  U.S.  cost  of  
 
treated AKI  per  Quality  Adjusted   year  life    (QAYL  )  was  estimated in 
 
1999 to be $50,000 per QAYL , a level that  raises concerns regarding the  
 
cost effectiveness of an treatment.  In a more recent analysis of long-term  
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outcomes  of  ICU    patients  who had recovered from  renal  failure  quality   
 
survival  was  poor—20   QAYLs  per  100 patient-years  in  the  first  year  
 
afterdischarge.  However  the  patients    health  satisfaction  was  not  
 
significantly different from that of the general .  
 
 
 
There  are  many problems  in    the  design  of  clinical  trails    that  have  
 
examined the  efficacy  of  several  novel  therapeutic  interventions  on  the  
 
acute  kidney injury . assessment   of  the effect of treatment  interventions  
 
in AKI is complicated by in accurately define the onset and resolution of  
 
AKI  .  In  addition,  most  clinical  trials  of  AKI  in  humans  have    limited  
 
because  of  an  imbalance  in  the  randomization  of  risk factors  among 
 
controls    and experimental  .  This  problem  could be  dealt  with    by 
 
stratifying patients before randomization  or ideally, by studying numbers  
 
of  patients    enough  for    adequate  randomization.  Therefore  an  accurate  
 
scoring systems  is    needed to classify   patients  enrolled in clinical  trials  
 
and also to allowing   physicians  to make  informed treatment  decisions  
 
regarding   medical  care  when  the  patient's  condition  make  further  
 
intervention reasonable . The two  most widely used  models for critically 
 
ill  patients  are  version  3 of  the  Acute  Physiology  and Chronic  Health 
 
Evaluation  (APACHE  3),  version  4   of  the  Acute  Physiology  Score  and  
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version  II  of  the  Mortality Probability  Model  at  48  hrs  .    These  models  
 
were developed for severe aki  patients  and although APACHAE 3  may 
 
have    in patients  requiring renal  replacement  therapy,  none  are  reliably 
 
features of outcome in the subgroup of patients with AKI. More recently,  
 
several  ARF  specific  indices  have  been developed,  but  this  indices  
 
outside  the  environment  in which  they were  developed is  uncertain.  In 
 
general,  although  several  of    scoring systems  are    developed from  an 
 
epidemiology  and research  context,  they remain  poor  determinants  of  
 
outcome  in  the  individual  patient.  Finally,  many  human  studies  of  ARF  
 
suffer  from  absence    of  well-defined   criteria.    Although  the  need for  
 
dialysis  has  been  used as  an  end point  in many  trials  of  ARF,  uniform  
 
endpoints    for  the  initiation  and continuation  of  dialysis  has  been  before  
 
the  study.  The  necessary  duration of  follow-up  to  fully capture  the  
 
sequelae of an episode of AKI is not known . Follow-up  of cases clearly 
 
extend  beyond ICU  discharge  and equally beyond hospital  discharge,  
 
because  there  is  evidence  that  mortality  rates  start  to  stabilize  after  3  
 
months following hospital discharge.  
 
 
 
Independent  renal  function is  attained in    most  patients  who survive  an 
 
episode  of  AKI  .  However,  40%  have  subclinical  functional    in 
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glomerular  filtration,  tubule  secretion  and  transport  ,  H+  secretion,  and  
 
urinary  diluenting    mechanisms,  and andbiobsy  for    glomerular  or  
 
tubulointerstitial  scarring .  AKI  is  irreversible  in  approximately 10%  of  
 
patients. It occurs because of  complete cortical  necrosis. It also requires  
 
long-term  renal  replacement  therapy  with  dialysis  or  sometimes  renal  
 
transplant is needed.  An additional 2 to 3 % of patients suffer progressive  
 
deterioration in renal function after an initial  phase, probably because of   
 
subsequent  sclerosis  of  remnant  glomeruli.    According to Experimental  
 
models  and of course in  humans who experience one episode of AKI are  
 
at increased risk of additional episodes of AKI on subsequent exposure to  
 
further  insults.  It  is  vital  to  note  that  the  subsequent    predisposition to  
 
acute  and chronic  renal  failure  may become  increasingly common   as  
 
human life expectancy increases.   
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RUSSEL VIPER  
 
 
 
It  is    characterized  by  presence  of  with    chain  of  rings  on  the  side  of   
 
vertebrae  and  three  or    more  chains  on  the  back  which  is  placed  
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symmetrically  on both side. It is a large and thick viper 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SAW SCALED VIPER  
 
 It  is characterized by a coils in the shape of eight all around the body .it  
 
is the most common  species causing envenomations . It is aggressive and  
 
with a sound of a saw cutting wood by rubbing its scale.  
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King Cobras have been found up to 18 feet long.  Its hollow fangs are up  
to 1/2 inch long. Poison is forced through the fangs when the cobra bites.  
 
The scaly skin glistens . Adults are  yellow, green, brown, or black.  The  
throat is light yellow or cream-colored. Juveniles are black with yellow or  
white  bars  crossing the  body.  The  King Cobra  smells  using its  forked  
 
tongue.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The  average  length  is  0.9 meter. Males  are  longer,  with proportionately 
longer  tails.  The  head is  flat  and the  neck hardly  evident.  The  body  is  
cylindrical.  tail  is    tapering  .  The  tail  is  short  and rounded.  The  eyes  are  
 
rather  small,  with rounded pupils.The  head shields  are  normal,  with  no  
loreals. The third and fourth supraoculars touch the eyes.[2] 
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NON POISONOUS SNAKES :  
 
GREEN VINE SNAKE  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GARTER SNAKE  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TEXAS  RA SNAKE  
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HOGNOSE SNAKE   
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DIFFERENTIATION  OF  POISONOUS  AND  NON  POISONOUS  
SNAKES: :  
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SNAKE BITE AND ITS COMPLICATIONS:   
 
 
 
Epidemiology:  
 
 
 
Viperidae  ,Elapidae    are  the  two most  common     poisonous  snakes 
 
species. Bite rates are more  in common in tropical  areas.it also occurs in 
 
the    temperate  parts  of    the  world   .  the  exact  rate  of  snake  bites  and its  
 
envenomations  and its  complications  including death  rates  are  not  
 
available in Indian registry. This is because of wide way of approach and  
 
treatment including the native treatments are done in our country.  
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Identification  :  
 
 
 
Each snake species is identified by its characteristics structure  
 
 
 
In case of  vipers,  for example  russel  viper it  is shown  by  its presence  of  
 
with  chain of rings on the side of  vertebrae.32 .  three or  more chains on 
 
the back .it is placed symmetrically  on both side. In case of russel viper It  
 
is a large and thick viper .it coils in the shape of eight all around the body 
 
.it  is the  most common  species causing envenomations . It  is aggressive  
 
and with a sound of a saw cutting wood by rubbing its scale .the teeth has   
 
long  mobile  fangs that  placed against the  roof of the  mouth. In   typical  
 
snake-venom,  the    venom  glands  situated below  the  eye.    it  was   
 
connected to hollow  anterior  maxillary  teeth  by  the    ducts.  In  case  of   
 
elapids and sea snakes, the  fangs are small.    it  was   in an erect position.  
 
poisioning occurs in 50% of all venomous snakebites.33 
 
  Dry  bites  means  there  is  no envenomations  on snake  bites.  This  can 
 
occur  in  around 60%  of  the  snake  bites.  It  is  common in the  tropical  
 
countries.  
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Venoms and Clinical Manifestations.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It    have  multisystem  effects  on  their  patients.  proteolytic  enzymes  
 
 
causes effects like local tissue necrosis  .  by the same mechanism it also  
 
 
causes  the  dysregulation  of  the    the  coagulation  pathway  .    in  case  of  
 
 
severe  envenomation  the  enzymes  released  by  the  snake  species  says   
 
 
Hemorrhagins  that  cause    vascular  leakage.  It    cause  both  local  and  
 
 
systemic bleeding.  Some species affects the cardiac output by the direct  
 
 
deprresent effects of the heart. Neurotoxins act  by varying mechanism .  
 
 
mostly  it  affects  the    peripheral  nerves  and  the  post  synaptic  ganglions  
 
 
..Viperids and some elapids cause progressive local swelling by release of  
 
 
enzymes like yylauronidase.  Pain, ecchymosis , and  hemorrhagic bullae  
 
 
and  serum-filled  vesicles    can  also  occur  by  the  same  mechanism.krait  
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cause  neurologic   
 
 
 
dysfunction  .In  serious  bites,  tissue  loss  can  also  occur    .  Changes  in  
 
 
taste,  mouth  numbness,  muscle  fasciculations  can  also  occur.  Similiarly  
 
 
tachycardia  or  bradycardia,  hypotension,  pulmonary  edema  can  also  
 
 
occur.  Complications  like  hemorrhage  ,  and  renal  dysfunction  can  also  
 
occur.34,  35.some  species  can  also  cause  neurologic  dysfunction    .tiger  
 
 
snakes , some cobras ,   
 
 
 
and  some  viperides    South  American  rattlesnake  and  some  Indian  
 
 
Russell's  viper  are  some  of  the  examples  .  following  are  the  neurologic  
 
 
dysfunction says . Ptosis, altered  mental status  ,respiratory  paralysis. It  
 
 
can  leads  to  respiratory  failure  and  aspiration  .  its  manifestations  
 
 
depends mainly on the type of species bitten and the amount of venoum  
 
 
injected  and  the  duration  of  the  delay  in  getting  teatment.  Sea  snake  
 
 
envenomation  usually  causes  local  pain  ,  myalgias,  rhabdomyolysis  .  
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Neurotoxicity occur.  
 
 
 
 
 
 
 
Treatment of Venomous Snakebite :  
 
 
Airway,  breathing,  and  circulation   are  the  initial  resuscitation   
 
measures.antivenom  administration  is  the  cornerstone  of  management..  
 
extremity should be kept  at approximately  heart  level .Splint  should be  
 
apply to    the  bitten  extremity to  lessen bleeding.  And it  should be  used  
 
only in  case  of      non  necrosis  snake  bites.  application of  poultices,  ice,  
 
and electric  shock should be  avoided     incising  wounds    should not  be  
 
done.Applying suction  to the  bite  should be  avoided.    These    are  
 
ineffective  and   can  local  tissue  damage..  Tourniquet  use  can  result  in 
 
amputation  and loss  of  function  ..In  case  of  neurotoxic  species  pressure- 
 
immobilization can be used .  
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HOSPITAL MANAGEMENT:  
 
 
 
   The  level  of  swelling in  the  bitten  extremity  should be  marked .  limb  
 
circumferences  measured every  15 min.  This  is      done  to assess  the  
 
progression of cellulitis.     patient should  be closely  monitored   for  vital  
 
signs, cardiac  function , oxygen saturation,  urine output . Swelling  size  
 
should be  measured     for    assessing the    progression  of  local  
 
envenomation. The extremity should be positioned at approximately heart  
 
level.    Large-bore  IV  access  in  the    extremities  should be  established.   
 
Pooling of  blood in the  pulmonary and splanchnic  vascular  beds  is  the  
 
reason for  early hypotension   .this  can  also  complicated by   systemic  
 
bleeding.  This  can be  managed  by  20–40  mL/kg  of  isotonic  saline.36    .  
 
5%  albumin    may  be  given  .  It  should be  given  when  patients  fail  to  
 
respond to saline  infusion.    Investigation  includes  .It  includes    complete  
 
blood count.    renal  and hepatic  function.  coagulation  studies.  testing  of  
 
urine for blood or myoglobin. The 20-min whole-blood clotting test  is a  
 
reliable  diagnosis  of  coagulopathy.        Dopamine  should be  added only 
 
after  aggressive  volume  resuscitation.  Antivenomadministration,  central  
 
venous  or pulmonary arterial pressures  can be helpful in such cases.  
 
 
 
Typing  and cross-matching    should be  done  .Blood should be  drawn  
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immediately  fo this.  And   laboratory  evaluation  as  soon  as  possible.  
 
Caution  of    any   vessel  puncture  in the  setting  of  coagulopathy,if  it  
 
happen  it  requires    direct-pressure  application  .  After    giving antivenom  
 
therapy  ,  laboratory  values  should be  rechecked every  6 h.    complete  
 
blood count  and coagulation studies  should be  repeated every  hour  .  20  
 
minutes  whole  blood clotting test  is  very useful.  This  consists  of    a  few  
 
milliliters of fresh blood are placed in a glass tube. undisturbed for 20 min  
 
and should checked whether    clot  has  formed.    Coagulopathy is  
 
diagnosedif blood not clotted in 20 minutes. Patients bitten by neurutoxic  
 
snakes    should be  watched carefully  .Evidence  of  cranial  nerve  
 
dysfunction  should b assessed.    It  includes    difficulty  in  swallowing ,  
 
respiratory insufficiency.  It  may  require  securing of  the  airway by 
 
mechanical ventillation.  
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Arterial blood gas studies, electrocardiography, and chest radiography can 
 
also warranted.  Administration    antivenom  is  the    vital    in the  
 
management  of  venomous  snakebite  .resulting  in    .  Antivenoms  are  
 
produced by  the  injection  of  venoms    into  animals  .    horses  or  sheepare  
 
commonly used. Antivenom antibodies  is  monospecific. Useful only  for  
 
a  particular  snake  species  .  there  are  also   polyspecific    antivenoms  
 
covering several medically important species in the region.  but it   cross- 
 
protection against snake species are rarely occur..After   animals develop  
 
antibodies to the venoms, their serum  is removed  and the antibodies are  
 
isolated . And  antivenom preparatiois made. It  includes  varying degrees  
 
of digestion and purification of the IgG molecules. The basic principle of  
 
antivenom  theraphy  is  thefollowimg.    Binding of  circulating venom  
 
components  before  they  can  attach to target  tissues.      So   antivenom  
 
selection  must be specific  for the offending snake. Because , it  may  lead  
 
to unnecessary  complications    if  the  antivenom  chosen  does  not  contain 
 
antibodies  to that  snake's  venom  components.  Indications  for  antivenom  
 
administration  include any evidence of systemic envenomation followed  
 
by   laboratory abnormalities and  local  findings  like  soft tissue swelling 
 
crossing a joint .  
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After the bite of an unidentified snake some species cause mild edema at  
 
the  bite  site    .  care  must  be  used   because  the  saliva  of  some  relatively 
 
harmless species can cause this. The efficacy of antivenoms in preventing 
 
tissue  damage  caused by necrotizing venoms  is  very  less.  It  may be  
 
impossible  to  prevent  necrosis  completely.  Because    venom  components  
 
bind to local  tissues  very  quickly—before  antivenom  administration  can 
 
be  instituted.  So   antivenom  administration should begin as  soon  as  
 
possible.  This  can  prevent        further  tissue  damage  and systemic  effects.  
 
In  such  bites,  antivenoms  are  useless  and potentially harmful.  If  there  is  
 
evidence  of  neurotoxicity  in  this  case  antivenom  administration  after  the  
 
bites  of  neurotoxic  elapids  is  indicated .  otherwise  is  not  indicated.  
 
Whenever  possible,  it  is  advisable  for  treating physicians  to  seek advice  
 
from  experts.    Opininon  obtained regarding  indications    and dosing of  
 
antivenom    In  case  of  viper    bites,  antivenom  administration  generally 
 
should be  continued as  needed until  the  victim  shows  definite  
 
improvement    .  Patient  should have    stabilized vital  signs,  reduced pain,  
 
restored coagulation.  It  is  difficult    to reverse  neurotoxicity  even  with 
 
antivenom once neurotoxicity is occurred. In such cases,  maintainece on 
 
mechanical ventilation  is the ideal one.  
 
 
 
 
 
74  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Use of any heterologous serum product  causes  risk of acuteanaphylaxis .  
 
delayed-type  hypersensitivity  reactions  can  also occur.  Skin testing  for  
 
potential allergy is insensitive and should not warranted.  Around 50 % of  
 
the patients can exposed to the complications of the anti snake ve om and  
 
its  complications  .  it  is  prevented by  the  pretreatment  with  IV  
 
antihistamine. Antivenom dose to be administered should be diluted in an 
 
appropriate  volume  of  crystalloid .  It  is  remembered that    antivenom  
 
should be  given  only by the  IV  route.  Epinephrine  at  a  dose  of  0.01  
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mg/kg,  up to 0.04mg/kg  can  be  given    prophylactic  subcutaneous  or  
 
intramuscular  dose  .  Modest  expansion of  the  patient's  intravascular  
 
volume with crystalloids may prevent  adverse reactions. Epinephrine and  
 
the infusion should be started slowly. The  physician at the bedside during 
 
the initial period to look for  the first signs of an acute reaction. Because  
 
serious complications like bronchospasm or acute cardiovascular collapse  
 
can  be  preventable  ..  The  decision to administer  further  antivenom  to a  
 
stabilized patient  generally  should be  based on  clinical  condition.  
 
Antivenom is effective only in reversing active venom toxicity; . The rate  
 
of  infusion  can  be  increased gradually  in  the  absence  of  a  reaction.  The  
 
dose  has  been  administered   over    period of  1 hour  .But    the  
 
complications  like  renal  failure  and compartment  syndrome  and  
 
neuropartalysis  can  only be  recover  after  some  period of  time  with 
 
effective suppoertive measures.   
 
 
 
In  case  if  the    patient  develops  an  acute  reaction to antivenom,  the  dose  
 
should be diluted further in isotonic saline.If the patient develops reaction 
 
to the antivenom the infusion should be temporarily stopped  it should be  
 
treated immediately treated  with IM  epinephrine  and  IV  antihistamines.  
 
Steroids may also be useful.  Once the reaction is controlled, and restarted  
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as  soon  as  possible.  Concomitant  IV  infusion  of  epinephrine  may  be  
 
needed.    The  patient  must  be  monitored  very closely.  An intensive  care  
 
setting, during such therapy.  
 
 
 
Blood products  are  rarely  necessary  in  the  management  of  an 
 
envenomated patient.   A drop in platelet count   hematocrit and   removal  
 
of  coagulation factors  can  occurs  in  some  of  the  snake  species.  Care  
 
should be  undertaken  in  giving  blood samples  to  the  coaguiopathy  as  it  
 
aggrevates or cause DIC in case of consumptive  coagulopathy.  
 
 
 
Rhabdomyolysis  and hemolysis  should be  managed in different  ways  .   
 
Victims  who develop acute  renal  failure  should be  evaluated  by a  
 
nephrologist.  They  may  require    peritoneal  dialysis  or  hemodialysis  .  
 
Renal failure in snake bites is usually is due to acute tubular necrosis and  
 
is    frequently  reversible.      Acetylcholinesterase  inhibitors  like  
 
neostigmine  can  be  useful  .It  is  useful  neurologic  dysfunction  after  
 
snakebite should  give a trial. If they If they respond, additional doses of  
 
long-acting neostigmine can be given. If bilateral cortical necrosis occurs,  
 
the  prognosis  for  renal  recovery  is  poor.    Renal  transplantation  may  be  
 
necessary in this case.  
 
 
 
Edrophonium  and  neostigmine    may cause  neurologic  improvement.  It  
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occurs in patients bitten by snakes with postsynaptic neurotoxins. Care  is  
 
required to prevent aspiration  in case of neostigmine administration.Care  
 
of  the  bite  wound includes  application of  a  dry,  sterile  dressing  .  
 
Splninting of the extremity with padding between the digits can be done.  
 
Once  the  administration of  antivenom  has  been initiated,  the  extremity 
 
should be  elevated above  heart  level  to prevent    edema.  Tetanus  toxoid  
 
should be  given  as  appropriate.  Prophylactic  antibiotics  are  generally 
 
unnecessary  because    the  incidence  of  secondary  infection is  low.    In 
 
some  regions,  secondary  bacterial  infection is  more  common .  In these  
 
regions, prophylactic antibiotics  are used commonly. Pain control should  
 
be achieved with acetaminophen or narcotic analgesics. NSAIDSs  should  
 
be avoided because of their effects on blood clotting.  
 
 
 
Manysnakeenvenomations  involve  subcutaneous  deposition  of  venom.  
 
But some  venom can be injected more deeply into muscle compartments.  
 
If  swelling in  the  bitten  extremity raises  concern  that  subfascial  muscle  
 
edema  ,  the  ICP  remains    high .  in such case  a  surgical  consultation for  
 
possible  fasciotomy should be  obtained.  Although  fasciotomy actually 
 
may  worsen  myonecrosis  in  some  cases.    compartmental  decompression 
 
is  still  required in case  to   preserve  nerve  function.    .  In such  cases  
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intracompartmental  pressures  (ICPs)  should be  checked.  A  dose  of  IV  
 
mannitol (1 g/kg) can be given in an effort to reduce  muscle edema. The  
 
incidence  of  muscle-compartment  syndrome  is  very  low  after  snakebite.   
 
Wound care  in the  days  after  the  bite  may require  careful    debridement  
 
.Remove the  necrotic tissue once coagulation has been restored.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 In case of serum-filled vesicles or hemorrhagic blebs  it should be should  
 
be  left  undisturbed.  If  ruptured,  they  should be  debrided with  sterile  
 
technique. Any debridement of damaged muscle should be conservative..  
 
 
 
Mortality and morbidity:.  
 
 
 
 Snakes  responsible  for  large  numbers  of  deaths    include  cobras  ,  carpet  
 
and saw-scaled vipers  ,  Russell's  vipers    and some  large  African  vipers.  
 
tropical rattlesnakes  can also cause mortality.  
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The    mortality rates  for  venomous  snakebite  are  low  in areas  with rapid  
 
access  to medical  care.  If  antivenoms  facillites    are  available  it  is  far  
 
less.The  incidence  of  morbidity  is  comparably  minimal  .  Morbidity  may 
 
be  due  to muscle,  nerve,  or  vascular  injury  .  Such morbidity  can  have  
 
devastating consequences for victims in the developing world .   
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SOURCE OF DATA :   
 
 
 
 
 
 
 
 
 
 
 
 
 
METHODOLOGY  
 
 
                               Snake bite patients who admitted in thanjavur medical  
 
college during the period of  January to August 2014 who also fulfills the  
 
inclusion and exclusion criteria   
 
 
METHOD OF COLLECTION OF DATA :  
 
 
                Sample size : 50 persons  
 
 
                Sampling method :  simple random sampling .  
 
 
INCLUSION CRITERIA :  
 
 
1. Snake bite of all species\  
 
2. Persons of all ages.  
 
 
EXCLUSION CRITERIA :  
 
 
1. Chronic kidney diseases  
 
2.  Unknown bite   
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  Male : female ratio   
 
 
Sex  
 
Male  
 
Female  
 
 
 
 
 
 
 
 
 
 
 
 
 
34 
 
 
 
 
 
 
 
 
RESULTS :  
 
 
 
 
 
 
No of patients  
 
  33  
 
17  
 
 
 
 
 
 
Sales 
 
0 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percentage   
 
66  
 
34  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
males 
females 
 
 
 
 
 
 
 
 
 
 
 
 
It  is  known  from  the  above  inference  that  the  males  are  more  prone  for  
 
the  snake  bite  induced  acute  kidney  injury  in  percept  of  environment  
 
interest. It may be due to the fact of local culture also   
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SPECIES OF SNAKE :   
 
 
sno  
 
 
Type of snake   No of patients  percentage  
 
1  
 
2  
 
3  
 
Saw scaled  
 
Russel viper  
 
Cobra  
 
12  
 
34  
 
4  
 
24  
 
68  
 
8  
 
Inference  from  the  above  table,  it  was  concluded  that  the  incidence  of  
 
acute kidney injury was high with the russel viper followed by saw scaled  
 
viper and cobra accounts for only few incidence   
 
 
 
 
 
 
 
 
0 
8 
 
24 
 
russel viper 
saw scalled 
68 
cobra 
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 COMPARISON OF AGE < 40 and > 40  
 
 
Age   
 
 
 No of patients  percentage  
 
Less than 40  
 
More than 40  
 
20 
 
30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 0 
 
40 
 
60 
 
 
 
 
 
 
 
 
 
 
age  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
less than 40 
more than 40 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the above table  it was inference that the more than 40 years of age  
 
are  more  prone  for  AKI  in comparison  with patients  aged less  than 40  
 
years   
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PERCENTAGE OF CELLULITIS IN  AKI:   
 
 
sno  
 
 
Cellulitis   
 
 
No of patients  percentage  
 
1 
 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
48 
 
present  
 
absent  
 
 
 
 
 
 
 
 
 
 
 
 
 
0 0 
 
26 
 
24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 
 
52 
 
48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
with cellulitis 
without cellulitis 
 
 
 
 
 
 
 
 
 
 
 
 
From  the  above  table    it  was  inference  that  the    52 %  percent  of  AKI  
 
patients is having underlying cellulitis as a cofactor and 48 % not  
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                PERCENTAGE OF COAGULOPATHY IN AKI :   
 
 
 
 
 
Present   
 
absent  
 
 
coagulopathy 
 
50 
 
0 
 
 
Percentage  
 
100   
 
0 
 
 
 
 
 
 
 
 
 
 
 
TIME OF 1ST DOSE OF  ASV ADMINISTRATION :  
 
 
Asv first dose  
 
Within 8 hours  
 
More than 8 hours  
 
 
No of patients  
 
28 
 
22 
 
 
percentage  
 
56 
 
44 
 
 
 
 
 
 
 
 
From the table it was inferenced that the  time interval of 1st dose of  asv 
 
whether it was within 8 hours or more than 8 hours have no big relation to  
 
the occurrence of acute kidney injury  
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asv   after 8 hours  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sales 
 
 
 
 
 
 
 
 
asv  before 8  
hours 
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asv within 8 hours 
asv after 8 hours 
 
 
4th Qtr 
 
 
 
 
PERCENTAGE OF LOW DOSE VS HIGH DOSE ASV CAUSING AKI   
 
 
asv  
 
Low  dose  
 
High dose  
 
 
 
 
 
 
 
 
70 
 
60 
 
50 
 
40 
 
30 
 
20 
 
10 
 
0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
 
No of patients  
 
18  
 
32  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
 
 
percentage  
 
36  
 
64  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Column2 
Column1 
Series 1 
low dose asv high dose 
 
 
 
From  the  table  it  was  inferenced  that  the    high  dose  of  ASV  is  not  
 
protective under AKI  
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PERCENTAGE  OF  PATIENTS  WITH  DEHYDRATION  PRONE  FOR  
 
AKI :  
 
 
 
 
 
 
Dehydration   
 
Present   
 
absent  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32 
 
 
 
 
 
 
No of patients  
 
34  
 
 16  
 
 
 
 
 
 
dehydration 
 
0 0 
 
 
 
 
 
 
percentage  
 
68  
 
32  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
present 
absent 
 
 
4th Qtr 
 
 
 
 
 
 
 
 
 
 
From  the  above    table  it  was  inferenced  that  the    dehydration    is  strong  
 
predictors of AKI  
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 PERCENTAGE OF PATIENTS WITH OR WITHOUT RISKFACTORS  
 
PRONE FOR AKI :  
 
 
Risk factors  
 
present  
 
absent  
 
 
 
 
 
 
 
100 
 
 
80 
 
 
60 
 
 
40 
 
 
20 
 
 
0 
 
 
No of patients  
 
3  
 
47  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Present 
 
Present 
 
 
 
 
 
 
 
90  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Absen
t 
 
 
percentage  
 
6  
 
94  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Absent 
 
 
 
 
 
 
 
 
PERCENTAGE  OF  PATIENTS  WITH  INTENSIVE  CARE  AND  
 
WITHOUT INTENSIVE CAUSING  AKI :  
 
 
 
 
 
 
Intensive care  
 
given  
 
Not given  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not given, 80 
 
 
 
 
 
 
No of patients  
 
10  
 
40  
 
 
 
 
 
 
 
 
 
 
Given, 20 
 
 
 
 
 
 
 
 
 
 
 
 
 
Given Not given 
 
 
 
 
 
 
 
 
 
 
 
 
 
91  
 
 
 
 
 
 
percentage  
 
20  
 
80  
 
 
 
 
 
 
 
 
DISCUSSION :  
 
 
                            This  is  a  retrospective  analysis  study  of  factors  
 
favouring acute kidney injury in snake bite patients   
 
 
                        50 patients  are  take  into account  who are  bitten  by  snake  
 
and was  admitted in  thanjavur  medical  college  who also fulfills  the  
 
inclusion and exclusion criteria   
 
 
               10 factors are take into account which are thought to be a reason 
 
behind causing acute kidney inury says  
 
 
1. Age   
 
2. Sex 
 
3. Species of snake   
 
4. Cellulitis  
 
5. Coagulopathy 
 
6. Time interval of first dose of asv 
 
7. High dose vs low dose asv  
 
8. Dehydration  
 
9. Risk factors for kidney injury 
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10.Intensive care vs general care   
 
 
SAMPLING TYPE :  
 
                Simple random sampling   
 
 
 
 
SUBJECTS : 50 
 
 
1.INCLUSION CRITERIA :  
 
 
                           1. Snake bite of all species  
 
 
                           2. Persons of all ages.  
 
 
EXCLUSION CRITERIA :  
 
 
3. Chronic kidney diseases  
 
4.  Unknown bite   
 
 
 
 
 
 
The  results  of  the  study  are  analyzed and was  plotted as  a  stataistical  
 
diagrams and the inference were noted .  
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1. ANALYSIS  OF  AGE  OF  PATIENTS  WHO  ARE  PRONE  FOR  
 
ACUTE KIDNEY INJURY :  
 
 
                 As  we  know    increasing age  is  an  independent  risk factor  for  
 
kidney injury   
 
 
Age   
 
 
 No of patients  percentage  
 
Less than 40  
 
More than 40  
 
20 
 
30 
 
40 
 
60 
 
 
 
 
 
Patients  more  than age  40 are  more  prone  for  acute  kidney  injury  .  
 
associated comorbide  illness  like  prehypertension,  impaiered glucose  
 
tolerance  and diabetic  mellitus  and hypertension    can  also be  a  cause  in 
 
patients aged more than 40 years   
 
 
 
 
 
 
Analysis of  type of species of snake that are more prone for AKI :  
 
 
AS  WE  KNOW  there  are  many types  of  snake  spcies  which  may  be  
 
poisonous or nonpoisonous   
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  There are also species which are neurotoxic , hemotoxic or myotoxic  
 
 
The  following  table  shows  the  comparison  of  three  common  type  of  
 
species of snake that are more prone for acute kidney injury   
 
 
 
 
 
 
sno  
 
 
 
 
 
 
Type of snake   No of patients  percentage  
 
1 
 
2 
 
3 
 
Saw scaled  
 
Russel viper  
 
cobra  
 
12 
 
34 
 
4 
 
24 
 
68 
 
8 
 
 
 
 
 
From  the  above  table  ,  it  clearly  shows  that  the  russel  viper  is  a  species  
 
which  most  commonly  associated with  acute  kidney  injury  in  a  term  of  
 
percentage  says  68 %  followed by  saw  scaled viper  in 24 %  and copra  
 
rarely causes  acute  AKI    
 
 
Analysis of cellulitis as a risk factor for acute kidney injury :  
 
 
      In  this  study  only cellulitis  that  cross  the  joint  space  is  taken  into  
 
account as a cellulitis that causing the AKI   
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 Localized cellulitis  is  common  in  any  insect  bite  that  may  be  due  to a  
 
local anaphylasis reaction :  
 
 
sno  
 
 
Cellulitis   
 
 
No of patients  percentage  
 
1 
 
2 
 
Present  
 
Absent  
 
26 
 
24 
 
52 
 
48 
 
 
 
 
 
According to our study cellulitis is found to be an moderate risk factor in 
 
term of causing acute kidney injury.   
 
 
More than fifty percent of patients are more prone for AKI  in comparison 
 
with  patients without cellilitis  
 
 
 
 
 
 
Coagulopathy and acute kidney injury :  
 
 
     Surprisingly our study has found that  all 50 patients in the studry are  
 
having underlying  coagulopathy . so from it we can come to a conclusion 
 
that  coagulopathy  and AKI  have  strong dependent  mechanism.  This  
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mechanism  may be  strong   influence  on  causing renal  tubular  acidosis  
 
and subsequent acute kidney injury .  
 
 
 
 
 
Present   
 
absent  
 
 
coagulopathy 
 
50 
 
0 
 
 
Percentage  
 
100   
 
0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The table shows all 50 patients in the study are having coagulopathy  as a   
 
underlying risk factors which is statistically very significant.  
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LOW DOSE VS HIGH DOSE ASV :  
 
 
 IT WAS  A CONCERN  ALL  OVER THE world  whether the high  dose  
 
of asv can prevent the complications of snake bites. But our study shows   
 
it  was  not  the  high  dose  asv    that  prevents  the  complications.  So even 
 
large number of patients in oue study aeround 32 were given large dose of  
 
asv , there is no reduction in the incidence of AKI.   
 
 
 
 
 
 
asv 
 
Low  dose  
 
High dose  
 
 
 
 
 
 
No of patients  
 
18 
 
32 
 
 
 
 
 
 
percentage  
 
36 
 
64 
 
 
 
 
 
THE  above  table  clearly  shows  that  the  high  dose  of  asv  is  not  protects  
 
against acute kidney injury. In oyr study we have taken 8 vbials of asv as  
 
a cutoff point out for high dose vs low dose asv.  
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Time interval OF 1ST DOSE OF ASV GIVEN  :  
 
 
       IT WAS believed from the long time that the administration of asv as  
 
early as possible can prevent the complications of snake bites.   
 
 
     But our study disbelieve this fact that the initiation of early asv is not  
 
protective against  complications of snake bites. So it was inference from  
 
this  fact  may  be  t  dose  or  amount  of  snake  venom  can  cause  this  
 
complications .  
 
 
 
 
 
 
Asv first dose  
 
Within 8 hours  
 
More than 8 hours  
 
 
 
 
 
 
No of patients  
 
28 
 
22 
 
 
 
 
 
 
percentage  
 
56 
 
44 
 
 
 
 
 
 
 
 
So it  is  clear  from  the  above  table  that  the  early  institution  of  asv  is  not  
 
protective against the complication of snake bite especially AKI.  
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DEHYDRATION/VOMITING :  
 
 
It  was  a  recent  interest  in the  field of  medicine  whether  the  dehydration 
 
caused by vomiting , anaphylactic shock to asv or by anyother cause can 
 
cause acute kidney injury as because dehydration is a known independent  
 
cause of any kidney insult.   
 
 
 
 
 
 
Dehydration   
 
Present   
 
absent  
 
 
 
 
 
 
No of patients  
 
34 
 
 16 
 
 
 
 
 
 
percentage  
 
68 
 
32 
 
 
 
 
 
So from  the  above  observation  it  was  clear    that  the  dehydration    is  the  
 
major  factor  contributing to the  development  of  acute  kidney injury in 
 
snake bite patients   
 
 
So correction  or  preventing  the  dehydration  can  largely  prevents  the  
 
development of acute kidney injury patients .  
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  INTENSIVE CARE :  
 
 
    It was done to find out is there any major change in occurrence of AKI  
 
if the patients were given intensive care set up.  
 
 
    Because  less number of patients were included in intensive care group  
 
in our study because in our study place most of the snake bite patients and  
 
patients  developed acute  kidney  injury were  managed in  general  ward  
 
itself.   
 
 
 
 
 
 
Intensive care  
 
given  
 
Not given  
 
 
 
 
 
 
No of patients  
 
10 
 
40 
 
 
 
 
 
 
percentage  
 
20 
 
80 
 
 
 
 
 
So it  is  very  difficult  to interperatefom  this  study  taking account  of  this  
 
small number of patients  about intensive care.  
 
 
 But  we  can  say  from  the  finding  of  large  number  pf  patients  were  
 
managed in  general  ward itself..we  can  come  to a  conclusion  indirectly 
 
that the there wont be any major change in intensive or general ward.  
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COEXIXTING RISK FACTOR FOR KIDNEY INJURY :  
 
 
        This includes pre  hypertension,  impaired glucose tolerance, diabetic  
 
mellitus, hypertension .  
 
 
As  we  know  all  this  factors  can  prone  kidney  injury  this  was  also  
 
analysed with snake bite patients,  
 
 
 But  in  our  study  most  of  the  patients  don’t  have  any  coexixting  risk  
 
factors  so it  helps  our  study to purely analyse  other  factors  in  causing 
 
AKI.  
 
 
Risk factors  
 
present  
 
absent  
 
 
No of patients  
 
3 
 
47 
 
 
percentage  
 
6 
 
94 
 
 
 
 
 
It is obvious that any coexisting risk factors can influence the incidence of  
 
acute kidney injury.  
 
 
Comparison with other studies :  
 
 
1. Jayantha  paul  et.al  studies  on  early  prediction  of  acute  kidney 
 
injury of  snake  bite  patients  correlates  better  with our  study  in 
 
perceptive of coagulopathy and hypotension.  
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CONCLUSION :  
 
 
1. COAGULOPATHY  HAS  BEEN  OBSERVED  IN  100%  OF  
 
SUBJECTS PRONED FOR ACUTE KIDNEY INJURY.  
 
2. DEHYDRATION  HAS  BEEN SECOND  MOST  FAVOURABLE  
 
FACTORS  IN  PREDISPOSING  ACUTE  KIDNEY  INJURY  IN   
 
SNAKE BITE PATIENTS .  
 
3. HIGH  DOSE  ASV    IS  NOT  PREVENTING  OR  REDUCING  
 
THE  INCIDENCE    OF  ACUTE  KIDNEY  INJURY  IN  SNAKE  
 
BITE PATIENTS  .  
 
4. EARLY INSTITUTION OF ASV IS ALSO NOT FOUND TO BE  
 
REDUCING  THE  INCIDENCE  OF  ACUTE  KIDNEY  INJURY  
 
IN SNAKE BITE PATIENTS.  
 
5. RUSSEL  VIPER  SNAKE  BITE  WERE  THE  COMMON  
 
SPECIES  ACCOUNTING  FOR  68%  OF  CASES  OF  ACUTE  
 
KIDNEY  INJURY  FOLLOWED  BY  SAW  SCALED  VIPER  OF  
 
24 % AND LEAST BY COBRA ACCOUNTS FOR 8 %.   
 
 
 
 
 
 
 
 
 
103  
 
 
 
 
 
 
 
 
6. PROGREESIVE  CELLULITIS  IS  NOT  FOUND  TO  BE  A  
 
MAJOR FACTOR IN CAUSING ACUTE KIDNEY INJURY.  
 
7. AGE  ,SEX,COEXISTING  RISK  FACTOR,  INTENSIVE  CARE   
 
ARE  FOUND  TO  BE  NOT  A  MAJOR  FACTORS  
 
INFLUENCING  THE  OCCURRENCE  OF  ACUTE  KIDNEY  
 
INJURY IN SNAKE BITE PATIENTS.   
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LIMITATIONS OF THE STUDY :  
 
 
1. NOT  INCLUDED  SUBJECTS  WITH  SIMILAR  UNDERYING  
 
FACTORS  AND  ARE  NOT  DEVELOPED  ACUTE  KIDNEY  
 
INJURY.  
 
2. PROGNOSIS OF ACUTE KIDNEY INJURY IS NOT ASSESED.  
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PROFOMA  
 
ANALYSIS OF FACTORS FAVORING ACUTE KIDNEY INJURY IN  
SNAKE BITE PATIENTS  
 
NAME :  
 
 
IP NO. :  
 
 
AGE :  
 
 
 
SEX:  
 
 
 
SPECIES OF SNAKE  BITE :  
 
 
 
CELLULITIS : PRESENT / ABSENT  
 
 
 
BLEEDING HISTORY:  
 
 
 
VOMITING /DEHYDRATION : PRESENT / ABSENT   
 
 
 
COMORBID ILLNESS: DIABETES/ HYPERTENSION/ OTHERS  
 
 
 
TIME INTERVAL OF FIRST ASV: < 8 HRS  /  > 8 HRS  
 
 
 
LOW DOSE VS HIGH DOSE ASV : < 8 VIALS / > 8 VIALS  
 
 
 
INTENSIVE CRITICAL CARE:  YES /NO   
 
 
 
EXAMINATION :    
 
 
 
PROGRESSIVE CELLULITIS PRESENT/ ABSENT  
 
 
 
INVESTIGATIONS:  
 
 
 
RANDOM BLOOD SUGAR:  
 
 
 
UREA:  
 
 
 
CREATININE:  
 
 
 
BT:  
 
 
 
CT:  
 
 
 
PT:  
 
 
 
INR:  
 
 
 
USG ABDOMEN:  
 
 
 
COAGUTIME INTERVAL  
 
 
 
INTENSI 
 
 
 
USG  
CELLUL LOW DOSE 
VS  
DEHYDR RISK  CREAT 
S.No. IP No. AGE SEX SPECIES ITIS LOPATH OF 1ST DOSE  Y ASV HIGH DOSE ATION FACTOR 
VE  
CARE 
 UREA  ININE ABDO 
MEN 
 
1 34607 43 M 
 
VIPER 
 
NO  YES  
 
3 HRS 
 
LOW 
 
YES  
 
NO  
 
YES 
 
118 
 
4.1 AKI 
2 35812 40 F UNKNOWN NO  YES  4 HRS HIGH YES  NO  NO 84 3.1 AKI 
3 36416 28 M SAW SCALED VIPER NO  YES  4 HRS HIGH YES  NO  NO 78 2.8 AKI 
4 36812 56 F UNKNOWN YES  YES  5 HRS HIGH YES  NO  NO 62 2 AKI 
5 36900 54 M VIPER NO  YES  3 HRS LOW NO NO  NO 96 3.1 AKI 
6 40104 38 F UNKNOWN NO  YES  14 HRS HIGH NO NO  YES 112 3.8 AKI 
7 41111 46 F UNKNOWN YES  YES  5 HRS LOW YES  NO  NO 90 3 AKI 
8 41284 42 M RUSSEL/VIPER NO  YES  8 HRS LOW YES  NO  NO 84 3 AKI 
9 46824 38 M 
10 46920 45 M 
11 47000 37 M 
VIPER 
UNKNOWN 
VIPER 
YES  YES  
YES  YES  
YES  YES  
3 HRS 
8 HRS 
14 HRS 
HIGH 
HIGH 
LOW 
YES  
NO 
YES  
NO  
YES 
NO  
NO 
YES 
YES 
100 
92 
78 
3.2 AKI 
2.8 AKI 
2.6 AKI 
12 52100 52 F SAW SCALED VIPER YES  YES  5 HRS HIGH NO NO  NO 114 3.6 AKI 
13 52380 46 M 
14 54830 34 M 
UNKNOWN 
UNKNOWN 
YES  YES  
YES  YES  
11 HRS 
3 HRS 
HIGH 
LOW 
YES  
YES  
NO  
NO  
NO 
NO 
94 
84 
3.2 AKI 
2.8 AKI 
15 55823 51 
16 57960 37 
17 58380 45 
F 
F 
F 
RUSSEL/VIPER 
VIPER 
RUSSEL/VIPER 
NO  YES  
NO  YES  
YES  YES  
8 HRS 
7 HRS 
11 HRS 
HIGH 
HIGH 
LOW 
NO 
YES  
NO 
NO  
NO  
NO  
NO 
NO 
NO 
68 
70 
112 
2.2 AKI 
2.8 AKI 
3.8 AKI 
18 59480 34 M 
19 60308 38 M 
UNKNOWN 
UNKNOWN 
YES  YES  
NO  YES  
5 HRS 
12 HRS 
LOW 
HIGH 
YES  
YES  
NO  
NO  
YES 
NO 
68 
86 
2.4 AKI 
2.8 AKI 
20 61832 48 M SAW SCALED VIPER YES  YES  12 HRS HIGH YES  YES NO 90 3.2 AKI 
21 62216 30 M UNKNOWN NO  YES  7 HRS LOW YES  NO  NO 80 2.6 AKI 
22 63128 51 F UNKNOWN NO  YES  6 HRS  HIGH NO NO  NO 94 3.6 AKI 
23 65122 36 M UNKNOWN NO  YES  6 HRS  LOW YES  NO  NO 68 1.8 AKI 
 
 
 
24 67000 54 M 
 
 
 
RUSSEL/VIPER 
 
 
 
YES  YES  
 
 
 
14 HRS 
 
 
 
LOW 
 
 
 
NO 
 
 
 
NO  
 
 
 
NO 
 
 
 
74 
 
 
 
2 
 
 
 
AKI 
25 68124 51 M UNKNOWN NO  YES  8 HRS HIGH NO NO  YES 96 2.8 AKI 
26 69012 40 F VIPER NO  YES  3 HRS HIGH YES  NO  NO 112 3.6 AKI 
27 70120 26 M VIPER NO  YES  4 HRS HIGH YES  NO  NO 80 2 AKI 
28 70280 60 M UNKNOWN YES  YES  7 HRS HIGH NO  NO  NO 110 3.2 AKI 
29 72328 46 M VIPER YES  YES  5 HRS HIGH YES  NO  NO 86 3 AKI 
30 73128 45 M 
31 75105 57 M 
RUSSEL/VIPER 
VIPER 
YES  YES  
YES  YES  
11 HRS 
7 HRS 
HIGH 
HIGH 
YES  
YES  
NO  
NO  
YES 
NO 
84 
76 
2.4 AKI 
2.4 AKI 
32 77128 37 F UNKNOWN NO  YES  5 HRS HIGH NO NO  NO 112 5.2 AKI 
33 77256 33 M UNKNOWN YES  YES  4 HRS LOW NO NO  NO 68 1.8 AKI 
34 77860 55 F VIPER YES  YES  7 HRS LOW NO NO  YES 80 3 AKI 
35 79058 38 M RUSSEL/VIPER YES  YES  10 HRS LOW YES  NO  NO 100 4 AKI 
36 80185 26 M 
37 80282 43 M 
UNKNOWN 
RUSSEL/VIPER 
YES  YES  
YES  YES  
8 HRS 
6 HRS  
HIGH 
LOW 
YES  
YES  
NO  
NO  
NO 
NO 
100 
78 
3.8 AKI 
2.6 AKI 
38 81428 50 
39 82210 38 
F 
F 
RUSSEL/VIPER 
VIPER 
NO  YES  
NO  YES  
5 HRS 
12 HRS 
LOW  
HIGH 
YES  
NO 
NO  
NO  
NO 
NO 
82 
68 
2.8 AKI 
2.2 AKI 
40 82410 41 M 
41 83280 42 M 
42 83418 52 M 
43 84860 48 M 
44 85098 31 M 
UNKNOWN 
UNKNOWN 
UNKNOWN 
VIPER 
RUSSEL/VIPER 
NO  YES  
YES  YES  
YES  YES  
NO  YES  
NO  YES  
7 HRS 
8 HRS 
10 HRS 
12 HRS 
6 HRS  
HIGH 
HIGH 
HIGH 
HIGH 
HIGH 
YES  
YES  
YES  
YES  
NO 
NO  
NO  
NO  
NO  
NO  
NO 
NO 
NO 
NO 
NO 
80 
92 
78 
86 
100 
2.8 AKI 
2.8 AKI 
2.2 AKI 
2.6 AKI 
3.2 AKI 
45 86092 28 F UNKNOWN NO  YES  5 HRS LOW NO NO  YES 92 2.8 AKI 
46 87121 56 F RUSSEL/VIPER YES  YES  4 HRS LOW YES  YES NO 98 3 AKI 
47 87434 34 M RUSSEL/VIPER YES  YES  11 HRS HIGH YES  NO  NO 64 1.8 AKI 
48 87521 38 M VIPER YES  YES  12 HRS HIGH YES  NO NO 72 2 AKI 
49 87548 42 M UNKNOWN NO  YES  8 HRS HIGH YES  NO YES 76 2.2 AKI 
 
 
 
50 88380 44 
 
 
 
F 
 
 
 
UNKNOWN 
 
 
 
NO  YES  
 
 
 
7 HRS 
 
 
 
HIGH 
 
 
 
YES  
 
 
 
NO 
 
 
 
NO 
 
 
 
84 
 
 
 
2.8 AKI 
 
 
 
                                                ABBREVIATIONS  
 
 
 
AKI- acute kidney injury  
 
 
 
RTA- Renal tubular acidosis  
 
 
 
ASV- Anti snake venom  
 
 
 
TT- TETANUS TOXOID  
 
 
 
PD- peritoneal dialysis  
 
 
 
HD- hemodialysis  
 
 
 
PT- prothrombin time  
 
 
 
CT- clotting time   
 
 
 
DIC- disseminated intravascular coagulation  
 
 
 
aPTT- activated partial thromboplastin time  
 
 
 
ATN- Acute tubular necrosis  
 
 
 
GFR- glomerular filtration rate 
 
 
 
 
 
 
 
CONSENT FORM  
 
 
 
 
 
I  __________________________________________    hereby give  consent  to  
 
participate  in  the  study  conducted by  DR.E.DEYAGARASAN  ,  post  graduate  in 
 
department of internal medicine ,Thanjavur medical college & Hospital, Thanjavur  
 
– 613001 and to use  my personal  clinical  data  and result  of  investigation  for  the  
 
purpose  of  analysis  and to study  the  nature  of  disease.  I  also give  consent  for  
 
further investigations. 
 
 
 
 
 
 
 
Place  :  
 
Date  :  
 
Signature of participant  
